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FACTORS AND OUTCOMES ASSOCIATED WITH POTENTIALLY INAPPROPRIATE 
MEDICATION USE IN RURAL COMMUNITY-DWELLING OLDER ADULTS 
Marcia Y Shade, PhD (c), MSN, BS, RN 
University of Nebraska, 2016 
Advisor: Ann M. Berger, PhD 
Potentially inappropriate medications (PIMs) use in older adults is a significant public 
health concern. The use of PIMs to avoid may lead to negative outcomes such as 
adverse drug events. Prior conceptual analysis of PIMs use and observation of health-
related factors in rural adults led to the design of this dissertation study. A sample was 
recruited from a population of rural community-dwelling older adults to examine the 
following specific aims: 1) Describe the use of PIMs to avoid, 2) Explore individual 
demographic characteristics (age, gender, income, education, and rural home location), 
health experience (comorbidity, number of medications and health providers), and health 
status factors (physical and mental function, sleep disturbance, sleep quality, and 24 
hours sleep-wake patterns) as predictors of use of PIMs to avoid, 3) Examine individual 
demographic characteristics, health experience, health status, and the use of PIMs to 
avoid as predictors of patient-reported adverse drug events (ADEs). One-on-one reviews 
of all prescribed and over-the-counter medications (OTC), vitamins, and supplements 
were performed on participants (N=138). The 2012 Beers Criteria were used to identify 
and record PIMs to avoid. Data were collected on: participant’s demographics, 
subjective physical and mental health and sleep; objective sleep-wake patterns, and 
patient-reported ADEs. Almost half (49%) of the sample of rural community-dwelling 
older adults used both prescribed and OTC PIMs to avoid. The most frequently used 
PIMs to avoid taken by participants were prescribed and OTC non-steroidal anti-
inflammatory drugs (33%), prescribed and OTC anticholinergic medications (28%), and 
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prescribed short-acting benzodiazepines (18%). The use of PIMs to avoid was 
associated with higher number of medications taken and medical providers (both 
p<0.001), and poor physical health (p<0.05). Higher number of medications was a 
significant predictor of an increased use of PIMs to avoid OR 1.8, 95% CI [1.19, 2.84]. 
One or more ADE was reported by 48% of participants; the most frequent being central 
nervous system (CNS) disturbances (16%), dry mouth (12%), hoarseness, 
gastrointestinal irritation, and decreased libido (8%). Higher patient-reported ADEs were 
associated with poor sleep and poor physical health (p<0.05). Younger age (65 to 78), 
poor physical health, and poor sleep quality were significant predictors of an increased 
probability of patient-reported ADEs (p<0.05). Implications for research include 
examining factors and outcomes associated with PIMs use in larger samples that 
compare both urban and rural primary care settings.  
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CHAPTER I: INTRODUCTION 
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CHAPTER I: INTRODUCTION 
BACKGROUND AND SIGNIFICANCE 
 An estimated 42% of community-dwelling older adults in the United States (U.S.) 
take medications that are potentially inappropriate (Davidoff et al., 2015). Potentially 
inappropriate medications (PIMs) are pharmaceutical products that have been 
determined to have risks that outweigh benefits according to the American Geriatrics 
Society Beers Criteria Expert Panel, (Radcliff et al., 2015). Prevalence estimates of the 
international use of PIMs in community-dwelling older adults are dependent on how they 
are measured, and reported to range anywhere from 22% to 56% (Moriarty, Bennett, 
Fahey, Kenny, & Cahir, 2015). PIMs use has vast implications for health safety and 
quality in older adults. Changes can occur in several body mechanisms that may 
increase the chances of harmful events as adults age. Polypharmacy, or the use of 5 or 
more medications, increases the risk of taking PIMs (Maher, Hanlon, & Hajjar, 2014). 
Older adults often have multiple chronic conditions and take numerous medications. An 
estimated 38% of older adults in the U.S. used at least 5 or more prescription drugs 
between 2007 and 2008 (Gu, Dillon, & Burt, 2010). Although the proper use of 
polypharmacy may be appropriate for maintaining stability of chronic conditions, health 
status, and symptom management, polypharmacy may lead to increased risk of drug-
drug and disease-drug interactions (Cadogan, Ryan, & Hughes, 2015).  
 Many drug-related interactions may lead to an adverse drug event (ADE). An 
ADE is defined as an injury resulting from a drug medical intervention. An ADE can be a 
medical error, an adverse drug reaction, allergic reaction, and/or an overdose (Kohn, 
Corrigan, & Donaldson, 2000). The occurrence of ADEs is a persistent problem and has 
gained national attention. National data revealed that ADEs precipitated millions of 
physician office and emergency visits (Bourgeois, Shannon, Valim, & Mandl, 2010; 
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Budnitz, 2011) both studies confirm previous analyses by Gurwitz and colleagues who 
reported 27% of ADEs occurred among patients 65 and older (Gurwitz et al., 2003). 
Ensuring that older adults avoid  inappropriate medications has implications for aging in 
place, maintaining health and preventing negative health outcomes, ADEs, and 
increased health costs (Dionne, Vasiliadis, Latimer, Berbiche, & Preville, 2013; 
Vasunilashorn, Steinman, Liebig, & Pynoos, 2012).  
Health professionals need to understand predictors of older adults PIMs use in 
urban and rural community-dwelling settings. Rural-dwelling older adults have higher 
rates of chronic illness, poorer overall health, and less access to care than in urban 
areas (National Conference of State Legislatures, 2013; National Rural Health 
Association, 2014). Nearly 90% of adults over age 65 want to remain in their home for as 
long as possible (Keenan, 2010). A goal of Healthy People 2020 is to improve the 
health, home function, and quality of life (QOL) of older adults and baby boomers who 
have high expectations for QOL and maintaining cognitive, physical, and social 
functioning (Potkanowicz, Hartman-Stein, & Biermann, 2009). The prevention and 
appropriate management of chronic diseases may help older adults in both urban and 
rural settings remain independent.  
Concepts 
A concept is an abstract phenomenon made up of one or two words that bear 
meaning, and are often placed into a theory and measured (Walker & Avant, 2011). The 
following paragraphs will provide explanation of the major concepts explored in this 
dissertation study; first with the major concept of PIMs use, followed by concepts that 
may predict PIMs use. These concepts were placed in a derivation of a nursing model to 
guide the dissertation study.  
Potentially Inappropriate Medication Use   
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  Chapter II provides an integrative review of PIMs use in community-dwelling 
older adults. The use of PIMs could lead to negative outcomes such as ADEs, increased 
hospitalizations, and health costs; all of which may impact the independence of an older 
adult (Finkle et al., 2011). The Beers Criteria was initially developed in the early 1990s 
for nursing home residents as a resource for health professionals, these criteria 
categorize high-risk medications in older adults based on their pharmacologic properties 
and the physiologic changes that occur in the older adult (American Geriatrics Society 
2012 Beers Criteria Update Expert Panel, 2012). The updated Beers Criteria includes 13 
drug combinations to avoid, a list of medications to avoid in older adults with poor renal 
function, three new medications and two medication classes to avoid in specific chronic 
diseases, and lastly several medications were removed or modified (Radcliff et al., 
2015). Polypharmacy and PIMs use are under-recognized in their association with 
hospital readmissions (Finkle et al., 2011; Sehgal et al., 2013).  
 As discussed in chapter II, most studies have not examined the conceptual 
problem of PIMs use and only observe medication lists or prescribed medications. The 
independent community-dwelling adult can obtain PIMs over the counter (OTC) and 
without a prescription (Shade, Berger, & Chaperon, 2014). Older adults are independent 
individuals and this factor is often neglected in studies of PIMs use in the community 
setting. Adults may seek OTC drugs due to increased prescription costs, limited access 
to healthcare, suggestions from family and friends, and increased direct marketing to the 
public (Basu, Dodge, Stoehr, & Ganguli, 2003; Chui, Stone, Martin, Croes, & Thorpe, 
2014). These factors differ from the institutionalized or hospitalized older adult whose 
medication regimens are routinely controlled and supervised. 
 Anticoagulants, antidiabetic, cardiovascular, analgesic, and central nervous 
system (CNS) agents have been reported as the most common drug classifications that 
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lead to ADEs (Salvi et al., 2012). The use of PIMs with anticholinergic effects may 
influence the CNS leading to altered balance and cognition (Koyama, Steinman, Ensrud, 
Hillier, & Yaffe, 2014). Community-dwelling older adults can acquire medications with 
CNS and or anticholinergic effects independently. 
Rural Community-Dwelling Older Adults  
          Rurality is a complex concept and may be measured in terms of demographics 
and socioeconomics. According to the Census Bureau, urban-rural classification is 
fundamentally a delineation of geographical areas, identifying both individual urban and 
rural areas in the nation. The Census Bureau has a strict definition of what is considered 
urban. An urbanized area includes 50,000 or more people or an urban cluster of at least 
2,500 and less than 50,000 people. Rural areas include populations, housing, and land 
not included within an urban area (U.S. Census Bureau, 2015).  
           About 13% of U.S. older adults live in rural areas (National Rural Health 
Association, 2014). Aging Americans that live in rural communities and are affected by 
health disparities, have issues with managing prescription costs, and poor coordination 
of services (Averill, 2012). Lower income and education have been associated with PIMs 
use in rural dwelling older adults (Blalock et al., 2005; Fu, Liu, & Christensen, 2004). A 
high proportion of older adults in rural communities are poor and have difficulty with 
access to health care; such as transportation and the ability to pay for services (National 
Conference of State Legislatures, 2013). As discussed in chapter III, obesity is common 
among adults living in rural areas, often leading to comorbid conditions (Befort, Nazir, & 
Perri, 2012). Less access and more out-of-pocket health costs may lead to poorer self-
care behavior choices. Other self-care behaviors may include the use of over-the-
counter medications, home remedies, contemporary supplements, and complementary 
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practices to manage chronic conditions (Basu et al., 2003; Eisenhauer, Hunter, & Pullen, 
2010).  
 In rural settings, fragmented and limited access to health care may lead to 
inadequate management of chronic diseases. Nurses in rural settings are in a unique 
position to ensure continuity of patient care. Nearly 24% of Licensed Practical Nurses 
(LPNs), 16% of Registered Nurses (RNs), and 1% of Nurse Practitioners live in rural 
areas and can form partnerships with patients to improve medication use and safety 
(Health Resources and Services Administration Bureau of Health Professions, 2013). 
The nurse has the ability and professional responsibility to assess the use of all 
medications, the use of PIMs, and to monitor for patient-reported ADEs (Boltz, 2012). 
Person-centered approaches that focus on appropriateness of medications may impact 
PIMs use and health outcomes. 
Health Status (Self-reported)        
 Health status is multi-dimensional and goes beyond objective measures of 
health. Health status includes physical health and behavior in addition to mental, 
emotional, and social functioning. Health status may have an important influence on the 
health decisions made by older adults. 
 Health Status. A patient’s perceived physical and mental health are components 
of health related QOL; often measured as outcomes. Health related QOL is a concept 
that includes measures of patient-reported physical and mental health (CDC, 2013).  A 
study by Fu and colleagues (2004) reported that U.S. older adults who used 
inappropriate prescription medications were more likely to report poorer health status as 
an outcome than those not using inappropriate prescription medications. In addition, the 
use of PIMs was common in a sample of community-dwelling older adults in New 
Zealand with perceived depressive symptoms (Lee et al., 2013). Common medications 
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classes to improve depressive symptoms such as serotonin–norepinephrine reuptake 
inhibitors, selective serotonin reuptake inhibitors, and tricyclic antidepressants are listed 
on the 2012 Beers Criteria (American Geriatrics Society 2012 Beers Criteria Update 
Expert Panel, 2012). Studies have not examined perceived physical and mental 
components of health status as predictors of PIMs use in rural community-dwelling older 
adults. Although they may be unaware of the risks, individuals with a poor perception of 
physical, emotional, or mental health may seek medications from health providers, the 
local pharmacy, or online websites to manage symptoms. 
 Sleep Quality and Sleep Disturbance. Sleep behavior is an important function 
of the human body. Sleep quality and sleep-wake disturbances are at times overlooked 
in association with health status in older adult populations. As seen in chapter III, there 
are significant relationships between poor self-reported sleep and high pain in obese 
mid-life and older rural women. These symptoms may not only impact health and chronic 
disease, but stimulate medication use. Some individuals seek sedative-hypnotics from 
primary care providers and others self-medicate with alcohol or over-the-counter sleep 
aids, with or without the knowledge of a health care provider (Basu et al., 2003). Sleep 
problems have been associated with the use of medications that promote sedation 
(Ancoli-Israel, Ayalon, & Salzman, 2008; Ancoli-Israel, 2009; Kryger, Monjan, Bliwise, & 
Ancoli-Israel, 2004). Medications with sedative properties have risks that outweigh 
patient benefits and are inappropriate for chronic use in the older adult (American 
Geriatrics Society 2012 Beers Criteria Update Expert Panel, 2012).  
Adverse Drug Events 
 Adults 65 years or older are twice as likely as others to come to emergency 
departments for adverse drug events and nearly seven times more likely to be 
hospitalized after an emergency visit (CDC, 2012). Although Budnitz et al. (2007) did not 
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find an association between the 2003 Beers Criteria and ADE-related emergency 
department visits, ADEs are still a substantial problem. In older adults, a 13% increase in 
the odds of an ADE (OR 1.13) was associated with an increase in the prescribing of 
inappropriate medications (Lund, Carnahan, Egge, Chrischilles, & Kaboli, 2010). 
Community-dwelling older adults have reported falls when taking PIMs on a regular and 
occasional basis and PIMs use has been associated with lower physical function, 
geriatric syndromes, and reductions in cognitive status (Beer et al., 2011; Berdot et al., 
2009). 
 Several medication categories (i.e. cardiovascular, non-opioid analgesics, 
hypoglycemic, and anticoagulants were associated with preventable ADEs in a sample 
of U.S. community-dwelling older adults (Gurwitz et al., 2003). U.S. older adults who had 
multiple comorbidities and took medications such as nonopioid analgesics and diuretics 
were at increased risk for ADEs in the ambulatory setting (Field et al., 2004). Other 
medications such as anticoagulants, opioids, and diabetic drugs have been targeted as 
part of an ADE Action Plan for the prevention of ADEs (Ducoffe et al., 2015). Although 
the prevalence of PIMs use in the community-dwelling older adult is evident, more 
studies are needed to address rural areas. In rural communities aging adults account for 
a larger share of the population and are becoming ethnically and culturally diverse (Rural 
Health Information Hub, 2016). 
 Studies of ADEs in community-dwelling older adults need to examine the patient-
report of ADEs in addition to medical records. A patient-reported symptom such as 
dizziness could be an ADE that goes undetected and is managed by the use of over-the-
counter medications or other self-care behaviors. More studies need to examine the 
relationship between PIMs use with the Beers Criteria; and patient-reported ADEs in 
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rural community-dwelling older adults in order to develop interventions to promote safe 
and quality health care. 
Theoretical Foundations 
 This dissertation study will be the first to prospectively examine PIMs use and 
ADEs using a nursing theoretical model. As shown in Figure 1. Cox’s Interaction Model 
of Client Health Behavior (IMCHB) is a middle range nursing theory developed in the 
early 1980s (Cox, 1982). The model represents the dynamic interactions that occur 
between the background and internal subconstructs of client singularity with elements of 
client professional interaction and health outcomes. The IMCHB has been adapted for 
this dissertation to include concepts that examine the relationships between the client 
singularity variables and health outcomes.  
 In the original model, client singularity was comprised of the background 
variables of demographic characteristics, social influence, health experience, and 
environmental resources. The internal variables included intrinsic motivation, cognitive 
appraisal, and affective response. Health outcome was comprised of five factors: 
utilization of health care services, health status indicators, severity of health care 
problem, adherence to treatment, and care satisfaction (Cox, 1982).  
 The IMCHB has been used to effectively examine medication decision-making in 
individuals with psychiatric illness (Mahone, 2004). The model has been previously used 
to examine functional outcomes and health behaviors such as exercise and adherence 
specifically in samples of older adults (Cox, 1986; Douglas, 2012; Fields, 2002; Lee & 
Laffrey, 2006). Cox’s IMCHB remains a popular model to evaluate patient behaviors and 
is useful for guiding research and developing person-centered interventions to achieve 
positive health outcomes (Chang et al., 2014). The target age of this study is 65 years 
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and older due to their increased risk of polypharmacy and PIMs use (Barnett et al., 2011; 
Buck et al., 2009; Maher et al., 2014). 
 
Figure 1. Cox’s Interaction Model of Client Health Behavior (IMCHB). 
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 The use of PIMs also has been associated with lower income and education in 
older adults (Blalock et al., 2005; Fu et al., 2004). Older adults living in rural communities 
receive care for multiple comorbidities and from general practitioners rather than 
geriatric specialists, a factor which has been associated with the use of PIMs (Blalock et 
al., 2005; Buck et al., 2009; Centers for Disease Control, 2013; Dall et al., 2013). The 
third predictor is health status and includes physical and mental health, sleep quality, 
sleep disturbance, and sleep-wake patterns. Sleep problems and depressive symptoms 
are associated with the use of several sedative and antidepressant medications that are 
listed on the 2012 Beers Criteria (Ancoli-Israel et al., 2008; Ancoli-Israel, 2009; Kryger et 
al., 2004) 
As seen in the model derivation in Figure 2, the client singularity factors include 
demographics, health experience, and health- status. The use of PIMs and patient-
reported ADEs will be explored as outcomes.  Based on the findings of this dissertation 
study, the IMCHB can be used for intervention development.  
SUMMARY 
 The purpose of this dissertation study was to explore the relationships 
and predictors of PIMs use. We used a derivation of the IMCHB to guide the study. 
Knowledge of PIMs use in rural community-dwelling older adults needs to be addressed 
to promote the safety of this population often challenged with health disparities. In 
general, research on PIMs use has been primarily led by pharmacists and physicians. 
 This dissertation has been prepared using the three manuscript format as 
approved by the supervisory committee. Chapter II provides an integrative review for the 
primary concept the use of potentially inappropriate medications (Shade et al., 2014). 
Chapter III explores the associations between self-reported sleep and pain, and 
objective sleep and health related factors in midlife and older rural women. The findings  
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Figure 2. Research Model of Factors Associated with Potentially Inappropriate 
Medication Use in Community Dwelling Older Adults adapted from Cox’s Interaction 
Model of Client Health Behavior  
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support significant relationships between poorer sleep and higher pain levels in mid-life 
and older rural women (Shade, Berger, Dizona, Pozehl, & Pullen, 2015). These factors 
may be predictors of increased odds of PIMs use and patient-reported ADEs. Chapter IV 
contains the manuscript of Aims 1 and 2 of the dissertation study and provides details of 
the methods, results, and discussion. Lastly, chapter V provides a summary and 
implications for future research and practice. Aim 3 of the dissertation study is included 
in Appendix A and will be submitted as a separate manuscript for publication. 
Purpose and Specific Aims 
 The purpose of this study is to explore the use of, and the factors associated 
with, PIMs and patient-reported ADEs in rural community-dwelling older adults ≥ 65 
years old. The specific aims were to: 
1) Describe PIMs use in rural community-dwelling older adults ≥ 65 years old. 
2) Investigate individual demographic characteristics, health experience and health 
status factors as predictors of PIMs use. 
3) Examine demographic characteristics, health experience, health status, and PIMs use 
as predictors of patient-reported ADEs.  
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Abstract 
  Potentially inappropriate medications (PIMs) are a significant world-wide public 
health problem. Community-dwelling older adults are susceptible to the possibility of 
negative outcomes associated with the use of PIMs. A database search produced 19 
prospective correlation and 10 intervention studies. The current state of the science 
reveals that the use of PIMs has been studied without clear analysis of the concept. The 
prevalence of the use of PIMs is well known from an abundance of descriptive studies. 
Researchers have not consistently examined their intervention’s effects on health 
outcomes in community-dwelling older adults. Although independent older adults can 
acquire inappropriate medications outside of a provider; current interventions are aimed 
at changing the behavior of the prescribing physician and pharmacist. Nurses need to 
participate in PIMs research and collaborate in interventions to reduce the use of PIMs 
and examine the effects of interventions health outcomes.  
17 
 
Introduction  
Potentially inappropriate medication (PIM) use is a problem related to safety in 
older adults. The prevalence of PIM use is approximately 50% in the older adult U.S. 
population, and many adults ≥ 65 years of age take at least one PIM (Beer et al., 2011). 
Commonly used PIMs are psychotropic drugs such as long-acting benzodiazepines, 
tricyclic antidepressants, and anticholinergic medications (Albert, Colombi, & Hanlon, 
2010; Bao, Shao, Bishop, Schackman, & Bruce, 2012; Bierman et al., 2007; Howard, 
Dolovich, Kaczorowski, Sellers, & Sellors, 2004; Lau, Mercaldo, Shega, Rademaker, & 
Weintraub, 2011; Lechevallier-Michel et al., 2005; Lin, Liao, Cheng, Wang, & Hsueh, 
2008; Maio, Yuen, Novielli, Smith, & Louis, 2006; Mort & Aparasu, 2000; Rochon et al., 
2004; Zhan et al., 2001). These drugs have been documented for being high risk with 
negative effects and limited effectiveness.  
According to the World Health Organization (WHO), an estimated 157 million 
Americans will be affected by at least one chronic condition requiring medication therapy 
by the year 2020 (Freudenberg & Olden, 2011). Older adults consume large numbers of 
medications, accounting for more than one-third of total outpatient spending on 
prescription medications in the US (National Institute on Drug Abuse, 2011). According 
to Gu, Dillon, & Burt (2010), 37% of adults age 60 and older use five or more 
prescription medications. Although the use of multiple medications (polypharmacy) may 
be necessary to manage chronic conditions long-term drug therapies can pose safety 
risks in the older adult.  
Background 
As the adult body ages, changes in pharmacodynamics and pharmacokinetics 
increase the hazards of medication use. Research has shown that the more medications 
are prescribed, the risk of PIMs increases (Blozik, Rapold, von Overbeck, & Reich, 
2013).  At times, side effects are mistaken for new onset illness or other comorbidities 
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that are treated with additional medications. This is sometimes referred to as the 
“prescribing cascade” and leads to additional PIMs (Knight & Avorn, 2001). PIMs can 
alter the central nervous system (CNS) and other mechanisms that increase the older 
adult’s risk for injury and hospitalization (Finkle et al., 2011). Older adults are vulnerable 
to adverse drug reactions (ADRs) and adverse drug events (ADEs) that relate to poor 
health outcomes, mortality, and increased health costs (Pretorius, Gataric, Swedlund, & 
Miller, 2013). The use of PIMs by older adults has been studied in the nursing home and 
acute hospitalization settings where pharmaceutical management includes medication 
monitoring. Older adults living independently may seek multiple care providers and 
pharmacies that increase the risk of acquiring PIMs. Disease-drug and drug-drug 
interactions, falls, and functional decline are consequences that can lead to reduced 
independence, and reductions of quality of life (QOL) (American Geriatrics Society, 
2012; Berdot et al. 2011).  
Providing quality geriatric care and health management involves optimizing 
medication use. Fick & Semla (2012) emphasized the importance of decreasing 
problems related to PIM use as an attempt to improve the health of older adults. The 
World Health Organization (WHO) (2008) calls for awareness and assessment of the 
risks and benefits of medicines, and the National Institute on Aging has set a goal of 
disseminating evidence to decrease older adult’s disease and disability and improve 
health and QOL (NIA, 2013).   
Health care professionals who are aware of the science surrounding PIMs in the 
community-setting are prepared to prevent the consequences of their use. The purpose 
of this state of the science is to appraise the definitions, methods, models, 
measurements, and results of the literature addressing PIMs in community-dwelling 
older adults. This appraisal will also identify gaps in the knowledge and recommend 
directions for future research.  
19 
 
Methods 
An electronic database search was conducted in June 2013 using CINAHL, 
MEDLINE, Biomedical Reference Collection, and PUBMED.  The time frame of January 
1991 through June 2013 was selected to identify specific articles based on the Beers 
criteria, which were first published in 1991. A keyword search included, but was not 
limited to: potentially, inappropriate medications, drugs, and prescriptions, 
polypharmacy, elderly, older adult, aged adult, community-dwelling, and home-dwelling.  
Journal articles were included based on the following characteristics: (a) study 
sample of adults 65 and older who were community-dwelling and living independently; 
(b) primary goal was to reduce inappropriate medications; and (c) article was published 
in the English language. Studies were excluded if they were conducted in a nursing 
home/skilled facility, or acute hospital inpatient setting.  Studies also were excluded that 
compared settings, examined specific disease states, explicit medications and tested 
instruments for measuring inappropriate medications, or if the a primary goal was not to 
reduce inappropriate medications.  
Identifying older adults prior to, or in the midst of using PIMs is helpful in 
decreasing medication-related complications. The age of ≥65 years was chosen to align 
with societal norms, such as eligibility for Medicare. Community-dwelling older adults 
possess the independence to obtain medications from local pharmacies or retail 
establishments. Professional monitoring of medication use is not heavily regulated in 
these settings compared to environments such as nursing homes and acute care 
facilities. 
Results 
 The search yielded 352 publications representing retrospective and prospective 
descriptive designs, intervention studies, and review articles. 285 Duplicates were 
removed leaving 67 articles for abstract review.  28 articles were limited to the exclusion 
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criteria. A manual search was performed on the identified articles to obtain additional 
studies 27 for review. After full-text examination the total of 38 retrospective, 19 
prospective and 10 intervention studies were selected. Figure 1 provides a flow chart of 
the results of the literature search.  
Definitions 
Experts have yet to come to a consensus on the definition of PIMs. Several 
terms are used interchangeably with PIMs including: medication misuse, potentially 
inappropriate prescriptions and potentially inappropriate prescribing; the latter two have 
been represented by the same abbreviation (PIP). Defining the concept of PIMs is 
essential in studying the problem.  Analysis of the concept of PIMs helps differentiate it 
from similar concepts. Dissection of each word and identification of attributes and 
antecedents allow for the conceptual definition to be derived (Walker & Avant, 2011). 
Conceptually PIMs are substances that may be unsuitable if taken for therapy. Attributes 
associated with the concept of PIMs in the independent community-dwelling older adult 
include: physician pharmacy, mis-communication, pharmacodynamics, 
pharmacotherapeutics, vulnerable, polypharmacy, and multiple chronic conditions. 
Antecedents of the concept of PIMs include recommending, advising, suggesting, 
advocating, proposing the use, and seeking of remedies that may be hazardous.  
Experts have developed a variety of methods to identify PIMs operationally. The 
Beers criteria are considered the foundation for PIM use in older adults (≥65 years of 
age). Medications should be prescribed based on a risk-benefit definition of 
appropriateness. The risk benefit definition of appropriateness declares a drug as 
appropriate if its use and potential benefits outweigh the potential risks (Beers, 1997). 
The definition derived from Beers and his colleagues was chosen for use in this analysis. 
Studies presented in this analysis include combinations of PIM and PIP literature due to 
overlapping definitions. PIP also lacks conceptual definition, and has been described as 
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potentially prescribing medications in high frequency, for long durations, in the presence 
of multiple medications with interactions, and the underuse of beneficial medications 
(Gallagher, Barry, & O'Mahony, 2007; Page,  Bryant, & Ruscin, 2010). A relationship 
exists between PIMs and PIP and studies regarding PIP are focused on the prescribing 
behaviors of the health care provider.  
Experts have reported associations between PIMs, ADRs and ADEs.  According 
to (Edwards & Aronson, 2000), the WHO has historically defined an ADE as “Any 
untoward occurrence that may be present during treatment with a pharmaceutical 
product, but does not necessarily have a causal relation to the treatment” (p. 1256). An 
ADR is a type of ADE that is defined as any harmful, unintended and undesired effect of 
a drug (WHO, 2008). Many reports use the terms interchangeably, do not define these 
concepts, or simply call them ADEs.  Other reports use related but unique terms such as 
adverse drug effects.   
Models 
The literature exemplifies underpinnings from a post positivist philosophical 
perspective. Studies were approached from the pharmaceutical models with minimal use 
of theoretical frameworks. Most models examining PIMS are pharmaceutical or medical 
in nature and lack conceptual definitions for what is being studied. The Andersen 
Newman Model is one sociological theoretic framework that has been used to explore 
PIMs in association with the societal and individual determinants of medical care 
utilization (Andersen & Newman, 2005). The model has been revised and has versions 
with the latest (phase 4) model involving the environment, population characteristics, 
health behavior, and outcomes. Feedback loops represent the circular effect of 
outcomes on predisposing factors (Andersen, 1995). Two teams have used this model, 
asserting better understanding of health care utilization and economical and humanistic 
outcomes resulting from the use of PIMs (Aparasu & Mort, 2004; Blalock et al., 2005). 
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The Andersen Newman model provides a theoretical approach on studying how 
PIM use can affect health service use. This model has the ability to predict and explain 
the use of health services (Andersen & Newman, 2005). The model is appropriate for 
use in the community dwelling older adult who is independent rather than the 
hospitalized or institutionalized adult. The model has been revised and has limited 
presence in current literature. A reason may be due to society’s ever-changing health 
care system and health care needs. Andersen (1995) claims the variables of the model 
have been criticized as being conservative, and outcome measures being unrefined. The 
Andersen-Newman model has the ability to predict and explain the use of health 
services for translational research for community dwelling older adults.  
Measurement 
 The literature provides several criteria to operationalize or quantitatively measure 
the concept of PIMs. However, due to the lack of conceptually agreed definitions, studies 
have used measurements to quantify PIMs and potentially inappropriate prescribing 
(PIP) equally. Tools have been developed worldwide and will continue to be revised as 
older adults and health care change. Most strategies have involved the Delphi method to 
determine appropriate versus inappropriate medications (Brown, 1968). The following 
section is a description of the most popular measurements of PIMs in community-
dwelling older adults. 
Beers Criteria 
In the US the Beers criteria were initially developed in 1991 in response to 
problems with medication use in nursing home residents. The list was revised in 1997, 
2003, and 2012 for use in all care settings (American Geriatrics Society 2012 Beers 
Criteria Update Expert Panel, 2012; Beers et al., 1991; Beers, 1997; Fick et al., 2003) . 
PIMs are categorized into medications to avoid in older adults regardless of diseases or 
conditions, and medications that are considered potentially inappropriate when used in 
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older adults with specific diseases or syndromes. The updated American Geriatrics 
Society (AGS) Beers criterion lists fifty-three medications or medication classes that are 
divided into three categories. The current criteria can be viewed at 
http://www.americangeriatrics.org/files/documents/beers/2012AGSBeersCriteriaCitations
.pdf. 
The Health Plan Employer Data and Information Set (HEDIS) criteria were 
recently updated (July 3, 2013) according to the 2012 AGS Beers criteria (NCQA, 2013).   
The consensus panel of the National Committee on Quality Assurance originally 
developed this quality measure to identify rates of inappropriate prescribing in the 
elderly. A past criticism of the Beers criteria claimed the list contained medications no 
longer commercially available or being used in clinical practice in the US. In the past the 
Beers criteria have also been criticized for not including over the counter (OTC) 
medications and not providing a list of alternative medications.  
 Physicians and pharmacists in several countries have used these criteria but 
have not had optimal success due to different medication formularies.  Fortunately, 
countries such as Germany and Norway have developed lists such as the PRISCUS and 
NORGEP to address PIMs in older adults based on their country’s commonly used 
medications (Holt, Schmiedl, & Thurmann, 2010; Rognstad et al., 2009).  
Medication Appropriateness Index (MAI) 
 The MAI was developed in the early 1990s to assess the appropriateness of 
medications. The 10 criteria include: indication, effectiveness, dosage, directions, 
practicality, drug-drug interactions, drug-disease interactions, unnecessary duplications, 
duration, and cost (Hanlon et al., 1992). The MAI has use for determining if medications 
are proper to prescribe, but the MAI does not list specific inappropriate medications for 
clinical guidance (Kaur, Mitchell, Vitetta, & Roberts, 2009). 
Other criteria 
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   The McLeod criteria were developed in Canada in 1997 as an attempt to expand 
the Beers criteria. Thirty-eight medications were placed into three categories: drugs 
generally contraindicated for elderly people, drug–disease interactions, and drug–drug 
interactions (McLeod, Huang, Tamblyn, & Gayton, 1997). The Zhan criteria also were 
developed in 2001 in response to an awareness of the limitations of the Beers criteria. 
Thirty-three drugs were placed in three categories:  medications that should always be 
avoided, rarely appropriate, and medications that have some indication but are often 
misused (Zhan et al., 2001).  There has been minimal application of the McLeod and 
Zhan criteria as a measure of PIMs in the current literature. 
  The screening tool of older person’s potentially inappropriate prescriptions 
(STOPP) was developed in 2008 by Gallagher and colleagues. STOPP contains 
commonly occurring PIMs in older people including drug–drug and drug–disease 
interactions, drugs that negatively affect older patients at risk of falls, and duplicate drug 
class prescriptions. This tool was intended to be used along with a screening tool to alert 
doctors to the right treatment (START), also developed by Gallagher (Gallagher et al., 
2008). The STOPP criteria are not used as widely as the Beers criteria in the community 
setting. The effectiveness of the STOPP criteria has been compared with the Beers 
criteria (Gallagher & O’Mahony, 2008). 
 Assessing care of vulnerable elders (ACOVE) was developed by the RAND 
Corporation (Santa Monica, CA) and Pfizer Corporation (New York, NY) to establish 
indicators that measure quality of care. A set of quality indicators was released that 
focuses on pharmacological care provided to community-dwelling vulnerable adults 
(Shrank, Polinski, & Avorn, 2007). Although promising, there are limited prospective 
interventions using this tool to study PIMs in community-dwelling older adults.  
Literature on PIMS in Community-Dwelling Older Adults 
25 
 
 The goal of the state of the science is to synthesize the results of the literature, 
identify areas of strength and weakness, and designate gaps in the science for future 
study. The current literature regarding PIMs in community-dwelling older adults consist 
of reviews relating to PIMs use in all settings, descriptive correlation studies, and 
prospective intervention studies. To our knowledge, this is the first review of the 
evidence related to PIMs in independent community dwelling older adults. 
Reviews 
Most reviews analyzed literature that included all settings in the community, 
nursing home, and hospital health care settings rather than focusing exclusively on 
community-dwelling older adults. (Gallagher et al., 2007) focused on the prevalence of 
inappropriate prescribing in older adults and Kaur and team (2009) provided a synthesis 
of evidence for interventions for reducing inappropriate prescribing in various settings. 
(Opondo et al., 2012) published the only review focusing on extent of inappropriate 
medication “prescriptions” given to older adults in the primary care setting. These 
reviews examined inappropriate medication use as a function of prescribing behavior, 
missing the opportunities that independent older adults have to acquire PIMs by means 
other than a provider’s prescription. A Cochrane review analyzed intervention studies to 
improve the use of appropriate medications in older adults (Patterson, Hughes, Kerse, 
Cardwell, & Bradley, 2012). The review reported poor methodology, design, and small 
samples in the studies. A  Jano & Aparasu (2007) review examined health outcomes 
associated with inappropriate medication use as defined by Beers’ criteria. The review 
concluded there is little existing evidence associating the use of PIMs in the community 
setting with mortality and health care utilization; however an association was noted with 
PIMs and increased hospitalization.  
Descriptive Correlational Studies 
Retrospective Studies 
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Retrospective cohort study designs are the primary type of literature describing 
PIMs in community-dwelling older adults. This design uses large databases of past 
patient information to describe the prevalence, frequency, risk factors, and outcomes of 
PIMs (Bierman et al., 2007; Buck M. D. et al., 2009; Cannon, Choi, & Zuniga, 2006; 
Chen et al., 2009; Fialová et al., 2005; Fick, Mion, Beers, & L. Waller, 2008; French et 
al., 2007; Hanlon, 2002; Klarin, Wimo, & Fastbom, 2005; Lin et al., 2008). 
Retrospective analyses have shown inconsistent results between PIM use and 
health outcomes. Some studies report an association between PIM use and adverse 
drug events, while others report no relationship (Budnitz, 2011; Chen et al., 2009; Fick et 
al., 2008; Hanlon, 2002; Lau et al., 2011).  Studies varied in results describing the 
association between the use of PIMs and functional status. One study reported the use 
of PIMs in association with a decline in basic self-care but another did not report an 
association (Hanlon, 2002; Lau et al., 2011). Retrospective designs are useful for 
analysis but have limitations that may lead to an under representation of PIMs. Studies 
are limited to the records included in the database, and influential data may be absent 
that lead to inaccurate results.  
Prospective Studies 
The authors identified 19 published prospective studies examining PIM use in 
community-dwelling older adults. The primary investigator was a pharmacist or 
physician. The studies examined the prevalence of PIMs solely or the association of 
PIMs with falls, ADEs, ADRs, and functional status. The prevalence of PIP was 
addressed specifically in community outpatient, ambulatory clinic, and pharmacy 
settings. Four studies conducted in different countries reported varying prevalence rates 
when examining PIMs within the home (Ay, Akici, & Harmanc, 2005; Fiss et al., 2011; 
Pitkala, Strandberg, & Tilvis, 2002). Additionally the prevalence of PIP in Portuguese 
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community pharmacies differs when compared to the home setting (de, Soares, Foppe 
van Mil, & Cabrita, 2006). 
Several factors influence PIM use in community-dwelling older adults also vary. 
Multiple medication use, comorbidities, female gender, and depression have been 
reported to increase the risk for PIM use (Blalock et al., 2005; Saab, Hachem, Sinno, & 
El-Moalem, 2006; Stuck, 1994). An adapted version of the Andersen Newman model 
was used to report that the risk of PIMs was higher in those with greater medication 
needs (Blalock et al., 2005). 
In Lebanon, Saab et al. (2006) was one of three studies that specifically 
addressed the use of OTC medications. The additional factors of alcohol and OTC drug 
use were associated with an increased likelihood of PIM use in older adults visiting a 
community outpatient clinic. The study reported an 18% missed dose frequency and 
13% incorrect frequency of medications used. The study reported PIM use prevalence 
higher than that reported by studies conducted in outpatient and ambulatory clinics in 
India and the US (Woelfel, Patel, Walberg, & Amaral, 2011; Zaveri, Mansuri, & Patel, 
2010). Literature related to the use of PIMs in the rural community is limited.  
A Nigerian study by Fadare, Agboola, Opeke, & Alabi (2013) investigated the 
prevalence of PIP for older adult patients being seen in a rural outpatient department. 
The prevalence was 25% higher than the study conducted by Ryan and team (2009) in 
an Irish primary care clinic. Ryan’s study compared urban and rural community-dwelling 
adults in addition to comparing two criteria of PIM measurements. Overall PIP 
prevalence was found to be 18% with the Beers criteria and 21% with the STOPP tool.  
  Prospective evidence is limited linking the relationship between PIMs and ADEs 
in community-dwelling older adults. Chrischilles, VanGilder, Wright, Kelly, & Wallace 
(2009) used surveys and self-report to determine a relationship between PIM use and 
adverse drug effects. The study did not examine ADEs but specifically looked at “side-
28 
 
effects” of PIMs. ADEs are commonly manifested as falls, orthostatic hypotension, heart 
failure, and delirium (Pretorius et al., 2013). In Taiwan Chang et al. (2005) found a 
positive association between potentially inappropriately prescriptions and possible ADRs 
(RR 15.3).  In France, Berdot et al. (2009) examined the differences in regular and 
occasional users of PIMs, and reported an increase risk of falling.  The odds ratios of 
falling were between 1.4 and 1.7 in regular users of psychotropic and anticholinergic 
medications and in occasional and regular users of long-acting benzodiazepines. An 
Australian study by Beer et al. (2011) reported 18.2% of community-dwelling older men 
ages 70 and 88 reported a fall that was associated with PIMs.  
A relationship exists between cognitive status and PIM use over time in 
community-dwelling women with dementia (Koyama, Steinman, Ensrud, Hillier, & Yaffe, 
2013). In Italy, Landi et al. (2007) reported that those using more than one PIM had 
significantly worse physical functioning. An older study in Chicago by Chin et al. (1999) 
reported that older adults presented to the emergency department with PIMs and were 
discharged with PIMs and these patients reported lower levels of quality of life.  
Lukazewski, Mikula, Servi, & Martin (2012)  reported PIM use is associated with 
increased geriatric syndromes, including memory and cognitive problems that place 
older adults at risk for adverse events.   
Interventions  
The authors found ten published interventions aimed at ultimately reducing PIM 
use in community-dwelling older adults (Table 1). Six of these studies were conducted in 
the US, and six lasted at least one year. The principle investigator was usually a 
pharmacist and one study was led by a nurse scientist. Interventions were geared 
toward changing the behavior of the prescribing physician and the monitoring of the 
pharmacist. Multifactorial approaches included medication review and screening, 
computerized, behavioral, and educational strategies. 
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Medication review and screening have been performed by teams or a 
pharmacist. Allard, Hébert, Rioux, Asselin, & Voyer (2001) longitudinal study used a 
multidisciplinary approach to conduct medication reviews in community-dwelling older 
adults at risk of losing autonomy in Canada. The intervention used a non-validated 
measurement tool and did not significantly decrease the number potentially 
inappropriate prescriptions. Pharmacists Dunn, Harrison, & Ripley (2011) used the 
Beers criteria as a screening intervention to alert physicians of PIMs. A reduction in the 
mean number of PIMs was found as patients were being seen in a US outpatient clinic. 
A pharmacist review intervention Taylor, Byrd, & Krueger (2003) reduced PIP, hospital 
and emergency room visits; and improved clinical levels of blood pressure, cholesterol, 
hemoglobin A1C, and coagulation values in older rural dwelling adults in Alabama. A 
similar study by  Hanlon et al. (1996) involved a clinical pharmacist and nurse who used 
the MAI to identify PIMs during medication reviews to reduce PIP in an outpatient 
Veteran’s Affairs clinic.  The study provided evidence supporting the implementation of 
dual nurse and pharmacist medication reviews to decrease PIP and potentially reduce 
ADE.   
 Computerized approaches were used to alert pharmacists when patients’ ≥ 65 
years were newly prescribed PIMs (Raebel et al., 2007; Simon et al., 2006; Tamblyn et 
al., 2003). Although the studies significantly impacted PIP, computerized support for 
prescribing may not give a complete depiction of the medication use of the patient. 
Prescriptions for PIMs could be obtained from other providers and taken to other 
pharmacies not connected with the intervention alert. Additionally, PIMs can be 
purchased OTC without the pharmacist being aware. These circumstances could 
increase the older adult’s risk of ADE’s.  
Three studies used educational and behavioral approaches to limit PIM use in 
older community-dwelling adults. The use of a multicomponent educational intervention 
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resulted in reductions in PIM use and exposure in Italian primary and outpatient clinics 
(Keith, Maio, Dudash, Templin, & Del Canale, 2013). In Denmark Bregnhoj, Thirstrup, 
Kristensen, Bjerrum, & Sonne (2009) used combined education and feedback to improve 
mean MAI scores. The only nurse-led study by Fick et al. (2004) used a strategy for 
behavior change in physicians to decrease PIM use of members continuously enrolled in 
a southeastern managed care organization.  
Discussion 
 This review includes an appraisal of the research specifically exploring the 
definition, models, measurement, and results of studies addressing the use of PIMs in 
community-dwelling older adult. A strength of the literature is that scientists descriptively 
studied PIM use and its association with negative health outcomes.  Researchers also 
have studied the effects of specific PIMs associated with specific diseases.  Descriptive 
studies provide varying findings regarding prevalence, influencing factors, and outcomes 
associated with PIMs. Studies relating PIMs to ADE’s, falls, and cognitive function are 
limited in the community-dwelling older adult. Also minimal research has been published 
focusing on interventions to reduce the use of PIMs and the resultant effects on health 
outcomes.   
PIM research is limited by the lack of concrete and conceptual definitions. This 
state of the science clarifies the vague conceptualization of PIMs to promote shared 
understanding of the problem among colleagues that will assist in the development of 
evidence based practice. The literature represents blurred concepts that do not share 
the same meaning. Potentially inappropriate prescriptions are instructions given by 
health care providers and PIMs can involve any substance for treating a disease with or 
without a prescription.  Assessing the prescribing behavior of the provider only examines 
one part of PIMs. Defined concepts should be placed into a research model and 
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measured operationally by tools that have established reliability and validity for that 
concept.   
In several studies, pertinent prior health history such as cognitive status was not 
addressed prior to data collection by self-report, interview or survey. Responses given 
on self-report measurements of ADEs or falls may be inaccurate if older adults 
experience decline in cognitive status. Other conditions may be considered as 
confounders in data analysis of the research. Interventions focused on physician 
behavior without considering patient behavior or involvement. Studies would benefit if 
they described participant’s medication seeking behaviors or beliefs about medications. 
This could provide additional insight on the use of PIMs from the perspective of the 
community-dwelling older adult for intervention development.   
The Beers criteria were most commonly used; however some medications on this 
list are not available in certain countries. Few researchers reported specifically including 
OTC medications in their studies. PIMs can be acquired OTC and without a prescription. 
Studies on PIMs would have access to all medications by including OTC medications in 
addition to prescription drugs. The reliability of secondary outcome measures often were 
not reported. Of the published interventions a few were complex and/or multicomponent. 
It is difficult to determine to what extent the intervention was effective because one 
component may be more effective than the other. Based on the review of the literature, it 
is difficult to draw conclusions in this area of research. 
This analysis examined the state of the science’s knowledge on the use of PIMs 
in community-dwelling older adults and is not without limitations. Journal articles may 
have been missed that represent the population of interest. Studies conducted in the 
outpatient, ambulatory, or clinic settings may not provide complete information regarding 
the residential living conditions of the participants. Older adults who live in the nursing 
home can be seen in these settings and several articles did not identify the specific living 
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arrangements of their participants.  The rationale for including these studies was an 
attempt to provide an analysis of any older adult living in community settings.   
Implications for Nursing Research     
 The increased number of older adults and the prevalence of chronic conditions 
are implications for enhanced nursing oversight of pharmacologic interventions in older 
adults (Edlund, 2010). Prospective studies are needed using conceptual models and 
rigorous methods with appropriate sample size, power, and reliable and valid measures.  
Nurse-led studies with interprofessional colleagues are needed addressing PIM use with 
health status and independence in community-dwelling older adults. Interprofessional 
teamwork can increase the translation of science to improve patient care    
Nursing professionals have not been engaged in studies addressing the 
prevention and use of PIMs in the community dwelling older adult. The nurse is an 
important member of the health care team; one who is trusted and in frequent contact 
with patients. The nurse frequently applies the skills of communication, monitoring and 
assessment of medication ADEs and ADRs. Teams of doctoral prepared nurses, 
advanced practice registered nurses (APRNs), pharmacists, and physicians can lead 
and evaluate interventions to reduce the use of PIMs. Studies with a PhD-prepared 
nurse as primary investigator can incorporate additional theoretical models into the study 
design for a different perspective. 
Randomized controlled trials with large sample sizes are needed when pilot 
studies demonstrate positive effects. Randomized studies are needed that compare an 
intervention group with a control group other than usual care. Qualitative or mixed 
methods approaches could provide further strength in analysis and interventions for 
reducing PIM use. The use of quality indicators such as ACOVE in studies as well as 
incorporating the current version of the Beers criteria (2012) would provide current 
33 
 
evidence to the science (Shrank, Polinski, & Avorn, 2007; American Geriatrics Society, 
2012).  
Future studies need to examine the use and prevention of PIMs in relation to the 
older adult’s family members, quality of life, health beliefs and behavior. Studies are 
needed that show the effects of medication optimization and tele-health strategies on 
PIMs and health outcomes. Collaborative and integrated models are best suited to 
respond to the chronic multi-morbidities of older adults and improve the pharmacological 
management of their conditions (Topinková, Baeyens, Michel, & Lang, 2012). A 
cooperative partnership between the nurse, pharmacist, provider, and patient may be 
the key.
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Figure 1. Flow chart of search results.  
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Table 1. Interventions Potentially Inappropriate Medication Use In Community-Dwelling Older Adults  
Author Design and Purpose Intervention Sampling and Setting Measures and Analysis 
Allard, Hébert, Rioux, Asselin, & 
Voyer, 2001 
 
RCT 
2 groups 
 
This was a 1-year longitudinal 
study. 
 
This is an intervention aimed at 
physicians to reduce potentially 
inappropriate prescriptions given 
to older adults. 
 
 
1. The team consists of 2 physicians, 1 
pharmacist, and 1 nurse reviewing the 
medications and diagnoses of the 
experimental group.  
 
2. The team’s suggestions were mailed to 
the primary care physicians justifying the 
changes.  
 
3. The nurse followed up monthly with the 
patient.  
 
Control group: The control group received 
normal health service 
N=266 patients  
Intervention: N=127  
Control: N= 130  
Age: ≥75 years 
  
Characteristics: Community- dwelling, at 
risk of losing autonomy, and taking >3 
medications. 
 
Quebec, Canada 
Potentially inappropriate prescriptions: 
Quebec Committee on Drug use list.  
 
Measures were completed before and 
after the intervention.   
Primary outcome: Number of potentially 
inappropriate prescriptions. 
 
Independent T tests 
Paired T test 
Analysis of covariance 
Results Limitations and Comments 
The intervention group had a larger 
decline in the mean number of potentially 
inappropriate prescriptions than the 
control, but this was not statistically 
significant. 
There were 38% of the participants in the 
intervention group that did not receive the 
intervention. 
 
A possible interaction occurred between 
the primary investigator and the 
physicians and patients.  
 
Attrition 
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Author Design and Purpose Intervention Sampling and Setting Measures and Analysis 
Bregnhoj, Thirstrup, Kristensen, 
Bjerrum, & Sonne, 2009 
 
RCT 
3 groups 
 
This was a 3-month study. 
 
This intervention was a 
combined or single educational 
intervention aimed at to increase 
the prescribing of appropriate 
medications among general 
practitioners (GPs).  
1. A combined interactive educational 
meeting plus feedback on patients’ 
medications.  
or 
2. A single interactive educational 
meeting  
or  
3. A control group (no intervention) 
 
N= 41 GPs 
N= 166 patients. 
Age: ≥65 years  
 
Characteristics: taking  >5 scheduled 
medications over a 3-month period prior 
to recruitment  
 
Denmark 
PIMs: Medication appropriateness index 
(MAI)  
MAI and number of medications in the 
intervention groups. 
  
Chi square test  
Wilcoxon signed rank test 
Results Limitations and Comments 
The MAI mean scores improved in the 
combined intervention groups by 5-points.  
The change in number of medications in 
the combined intervention group had a 
significant decrease of −1.03 (95% CI 
−1.7 to −0.30). 
The level of appropriateness of the 
medication may be overestimated due to 
the collection method (GPs and medical 
records). 
 
The Hawthorne effect could have 
occurred. 
 
The GP served as gatekeeper for 
medications 
Author Design and Purpose Intervention Sampling and Setting Measures and Analysis 
Dunn, Harrison, & Ripley, 2011 
 
Non-randomized prospective 
pre/post pilot study 
 
This intervention is aimed at 
decreasing the use of PIMS by 
conducting outpatient screening. 
1. The medication profiles of the 
participants were screened using the 
Beers criteria before a patient’s 
scheduled appointment.  
 
2. The doctors were informed of PIMs 
and given options to discontinue, 
continue, or change the medications.  
 
3. The medication profiles were followed-
up after the appointment. 
6 individual medicine and medicine 
specialty clinics. 
N= 120 charts of patients 
Age: ≥65 years 
  
USA 
PIMs: Beers criteria 2003 
 
Dependent measures t-test 
Results Limitations and Comments 
37.5% of the subjects were taking PIMs. 
There was a statistically significant 
decrease in the mean number of Beers 
criteria medications p=.032. 
The accuracy of the medication profiles 
was unknown. 
 
The knowledge of the Beers list among 
health care team was unknown.   
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Author Design and Purpose Intervention Sampling and Setting Measures and Analysis 
Fick et al., 2004 
 
Randomized block design 
2 groups 
 
This was an 18-month study.   
 
This intervention was designed 
to change physician behavior 
and decrease potentially 
inappropriate prescribing (PIP) in 
older patients. 
 
1. The physician received a detailed 
brochure listing PIMs, suggested PIM 
alternatives, and a personally addressed 
letter from managed care organization 
(MCO) describing the patients taking 1 or 
more PIMs. 
  
2. The physicians were invited to 
comment on PIM changes by using a fax-
back form. 
 
Control group: usual care 
N = 355 Medicare and choice  
product line of southeastern  
MCO physicians 
Intervention group: N=170 physicians  
Control group:  N=185 physicians 
Age:≥65 
  
USA 
PIMs: Beers criteria 1997 
 
Descriptive investigation of physician 
response to the PIMs responded to, and 
the action taken. 
 
Chi square tests 
Results  Limitations and Comments 
69.4% providers prescribed at least 1 
PIM.   
71% physicians responded back with the 
fax. 
12.5% physicians discontinued the 
medication, 1.7% modified dosage, and 
1.2% used alternative medication.  
The # of continuously enrolled members 
with at least 1 PIM declined from 19.4%-
17.9% (p<.001). 
The fax was not an efficient form of 
communication. 
   
The initial education brochure that was 
given 3 months prior to the study may 
have had an effect on the actual reality of 
the prescribing practices.   
Author, Design, and Purpose Intervention Sampling and Setting Measures and Analysis  
Hanlon et al., 1996 
 
RCT 
2 groups 
 
This was a 1-year study 
 
This was an intervention to 
decrease PIP in outpatients. 
Intervention group: Received usual and 
clinical pharmacist care. 
Usual care: a nurse reviewing current 
medications before and after their visit 
Clinical Pharmacist care: 
1. Prior to the visit the clinical pharmacist 
monitors drug therapy, identifies drug 
related problems and meets with patient 
and caregivers.  
2. Suggestions from the pharmacist are 
given to the physicians.  
3. The pharmacist provided patient 
education following the physician visit.  
4. The pharmacist provided compliance 
strategies to the patient. 
Control group: usual care 
General Medicine Clinic, 
N=208 
Intervention group: N=105 
Control group: N=103 
Age: ≥ 65 years, taking ≥5 medications 
from a Veterans Affairs Medical Center. 
 
USA 
PIMs:  MAI criteria 
 
Student T-tests  
Chi square or Fisher’s exact test  
ANCOVA and MANCOVA on other 
outcomes.  
Baseline, 3 –month, and 12-month 
measures.   
Results Limitations and Comments 
At 3 months the intervention group had a 
decline in PIP when compared to the 
control group (p=.0006) and was 
consistent at 12 months (p=.0006). 
 
Fewer patients experienced ADEs but 
this was not statistically significant. 
There was patient randomization without 
physician randomization. 
 
This study focused on regularly 
scheduled medications only and did not 
include as needed or over-the- counter 
(OTC) medications. 
Author Design and Purpose Intervention Sampling and Setting Measures and Analysis 
Keith, Maio, Dudash, Templin, & 
Del Canale, 2013 
1. The physicians received a list of PIMs 
to always be avoided with alternatives, 
Stratified by location 
N= 303 General Practitioners (GP) in the 
PIMs:  modified Beers criteria 
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Prospective study 
2 group design 
 
This was a 3-year study 
 
This was a multicomponent 
intervention designed to 
decrease potentially 
inappropriate prescribing (PIP) to 
older patients in primary care. 
annual reviews of PIM incidence data. 
 
2. Educational sessions on PIMs via 
academic information and case study 
reviews were done with the physicians. 
 
Reggio Emilia LHA was the comparator 
and received usual care. 
Parma Local Health Authority (LHA)  
N= 325 GPs in Reggio Emilia LHA. 
Age: ≥65  
Parma LHA N= 78482 patients at 
baseline 
Reggio Emilia LHA N= 81,597 at baseline 
 
Italy 
Outcomes: 
1) The percentage of change in PIMs 
from baseline 2007 4
th
 quarter to the end 
of the study post intervention 2009 4
th
 
quarter.   
2) The significance of change in 
incidence rates over time within each 
LHA  
 
Chi square and estimated percentage of 
change 
Results Limitations and Comments 
Both LHAs experienced reductions in PIM 
exposure rates.  
The patient diagnosis data was not in the 
database 
 
The inpatient prescriptions and OTC 
medications were not available. 
   
There were possible confounding 
variables.   
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Author Design and Purpose Intervention Sampling and Setting Measures and Analysis 
Raebel et al., 2007 
 
RCT 
using a 2-arm parallel-design 
 
This was a 1-year study. 
 
This intervention was designed 
to reduce newly prescribed PIMs 
in older adults.  
1. The pharmacist was alerted when a 
patient ≥65 was prescribed one of 11 
medications. 
 
2. The pharmacist alerted the provider 
and made notes in the computer system.   
 
Control group: wait-listed for 6 months 
with usual care during that time period. 
At Kaiser Permanente (KP) Colorado, a 
group model US Health maintenance 
organization (HMO), 
Age: ≥ 65  N=59,680  
(29,840 each group).   
Physicians, patients, and pharmacists 
blinded to group assignment. 
  
USA 
PIMs: physicians and pharmacists 
collaboration using Beers criteria, Zhan 
criteria and KP list of medications to avoid 
in older adults. 
 
Chi square and Wilcoxon rank and Fisher 
exact tests 
Results Limitations and Comments 
There was a higher percentage of PIMs 
prescribed in the usual care group 2.2% 
than in the intervention group 1.8%.   
The most common prescriptions reduced 
were amitriptyline (p<.001), and 
diazepam (p=.02). 
The use of health plan prescription data 
to assess drug dispensing does not 
ensure that patients did not go other 
places for prescriptions. 
 
This study did not consider the refilled 
prescriptions as PIMs for alerts.   
Author Design and Purpose Intervention Sampling and Setting Measures and Analysis 
Simon et al., 2006 
 
Cluster  
RCT 
Interrupted Time Series Analysis 
2 groups 
 
Study conducted over 3- years. 
 
This intervention was designed 
to reduce newly prescribed PIMs 
in older adults. 
1. The computer system gave age-
specific alerts when older adults were 
prescribed specific PIMs.  
 
2. The physician also received academic 
detail which is evidence-based education. 
 
Group 1: Alerts and academic detail 
intervention 
Group 2: Alerts only 
Clinic sites total N=15 
Group1: N=113 with 7 sites 
Patients=24,119 
Group 2: N=91with 8 sites 
Patients: N=26,805 
Age:  ≥65 
 
USA 
PIMs: Investigator developed instrument 
 
PIMs dispensed per 10,000 patients per 
quarter 
 
T-tests 
Chi square 
Segmented regression models 
Results  Limitations and Comments 
There was a downward trend occurred in 
alerts for targeted medications being 
dispensed. 
 
The academic detailing did not 
statistically change the number of PIMs 
dispensed. 
 Generalizability 
  
53 
 
Author Design and Purpose Intervention Sampling and Setting Measures and Analysis 
Tamblyn et al., 2003 
 
Clustered 
RCT 
2 group design 
 
This was an intervention to 
reduce inappropriate 
prescriptions given to older 
adults.  
1. The physicians were given 
computerized decision making support 
(CDS) consisting of a computer, health 
record software, and internet capabilities. 
 
2. The physicians were given downloaded 
updates on prescriptions that were 
dispensed to their patients from the Regie 
de l’assurance maladie du Quebec 
(RAMQ) drug insurance program. 
  
3. Alerts were generated describing the 
problem with the medication, 
consequences, and alternative therapies. 
 
Control group: usual care 
N=107 primary care physicians 
N=12560 patients 
(aged ≥66, community-dwelling, and been 
seen on at least 2 occasions by their 
physician) 
Intervention group 
N=54 
Control group 
N=53 
 
Quebec, Canada 
Primary Outcomes: Initiation and 
discontinuation rates of those given at 
least one inappropriate prescription.  
 
Prescribing problems 
 
Descriptive statistics 
Pearson correlation 
Poisson regression with generalized 
estimating equation 
Results  Limitations and Comments 
The number of newly prescribed 
inappropriate medications per 1000 visits 
was lower in the CDS group by 18% 
when compared to the control group [RR 
0.82].  
A non-statistically significant 
discontinuation (14%) of preexisting 
inappropriate prescriptions occurred in 
the CDS group.  
 
There was a significant difference in the 
discontinuation of prescriptions for drug-
interactions among 68.6 per 1000 visits in 
the CDS group versus 51.5 per 1000 
visits in the control group.  
Drug disease, drug-age, and excessive 
duration were common prescribing 
problems. 
The previous computer experience of the 
physician was unknown. 
 
The patients received care from at least 3 
other physicians prescribing medications. 
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Author Design and Purpose Intervention Sampling and Setting Measures and Analysis 
Taylor et al., 2003 
 
RCT 
2 group 
 
This was a 1 year study. 
 
Prevention and monitoring of PIP 
and drug-related problems in 
older rural dwelling adults. 
1. The patient met with one of 4 
pharmacists for 20 minutes before seeing 
the physician. 
 
2. The pharmacist used published 
algorithms and guidelines to make 
recommendations to the provider. 
  
3. Written and oral education was 
provided to the patient. 
 
The intervention group received usual 
care plus pharmaceutical care. 
 
The control group received usual care. 
 
3 community 
family medicine clinics in rural Alabama 
Intervention 
N= 33 
Control 
N= 36 
 
USA 
PIP: MAI 
Clinical endpoints: Blood pressure, 
hemoglobin A1C, Low density 
lipoproteins, and International Normalized 
Ratio. 
 
Number of hospitalizations and 
emergency department visits and quality 
of life. 
 
RMANOVA 
T-tests 
Chi square 
Results  Limitations and Comments 
The number of hospitalizations and 
emergency room visits decreased in the 
intervention group p=0.003. 
 
The intervention group was closer to or 
meeting the goal blood pressure, 
Hemoglobin A1C, cholesterol, and INR 
levels.   
Quality of life changes were not 
significant 
 
The percentage of PIP decreased in the 
intervention when compared with the 
control group.   
Small sample 
Short follow-up period 
Physicians were not randomized, only the 
patients 
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Abstract 
This secondary analysis describes sleep and health-related factors in healthy 
overweight and obese mid-life and older rural women enrolled in the “Women Weigh-In 
for Wellness” randomized clinical trial. The aim of the trial was to promote healthy 
behaviors and weight-loss. We analyzed demographic, anthropometric, and biomarker 
variables, self-reported measurements of sleep disturbance and pain interference, and 
objective 24-hour sleep/wake patterns at baseline, 6 months, and the change over time. 
Although self-reported sleep disturbance reflected normal sleep, pain interference was 
slightly higher than normal. There were associations between higher self-reported sleep 
disturbance, pain interference and several other variables. Women who achieved 5% or 
more weight loss exhibited positive associations between sleep, pain, and health-related 
factors. Weight loss and lower pain predicted lower self-reported sleep disturbance. Our 
results suggest that overweight and obese rural women who adopt healthy behaviors 
and achieve weight loss also may experience improved sleep and other health benefits.  
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Introduction 
The worldwide prevalence of obesity has increased dramatically. Over two-thirds 
of adults in the United States (US) are considered overweight and one-third are 
considered obese (Centers for Disease Control, 2014; Ogden, Carroll, Kit, & Flegal, 
2014). The US has reported higher rates of obesity than other countries, in rural areas, 
and in women (Befort, Nazir, & Perri, 2012; Hartz et al., 2007; Organization for economic 
cooperation and development, 2012). Higher obesity trends have been paralleled by 
reports of short sleep duration and are likely to contribute to poor health outcomes of 
Americans (Centers for Disease Control and Prevention (CDC), 2011; Patel et al., 2008; 
Singh, Drake, Roehrs, Hudgel, & Roth, 2005; Vgontas et al., 2014).  
Sleep duration of 7-9 hours each night is recommended for optimal health 
(Hirshkowitz et al., 2015; Watson et al., 2015). Prior evidence has suggested that short 
self-reported sleep duration and poor sleep quality are risk factors for the development 
of obesity; but trends have been most consistent in children (Beccuti & Pannain, 2011; 
Grandner, 2012; Hung et al., 2013; Nielsen et al., 2010). In adults, short self-reported 
sleep duration has been associated with several factors such as female gender, older 
age, higher BMI, waist circumference, and hypertension (Befort et al., 2012; Di Milia, 
Vandelanotte, & Duncan, 2013; Hartz et al., 2007; St-Onge et al., 2010; Theorell-
Haglow, Berglund, Janson, & Lindberg, 2012). Regardless of previous sleep patterns, 
American women who reported sleeping 7 hours or less duration per night were more 
likely to be obese (Anic, Titus-Ernstoff, Newcomb, Trentham-Dietz, & Egan, 2010). 
Among those living in rural America, short self-reported sleep disturbance was 
associated with obesity-related risk factors such as less physical activity, low intake of 
healthy foods, and high fat and fast food consumption (Stamatakis et al., 2008). In 
addition, short self-reported  sleep duration of 6 hours or less was found to be 
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significantly associated with higher body mass index (BMI)  in men and women living in 
rural Iowa (Kohatsu et al., 2006). The risk of insomnia symptoms has been reported to 
be increased among individuals in rural areas with poor health, older age, female 
gender, low income and education (Hartz et al., 2007). Rural health disparities, behavior 
patterns, culture, socioeconomic, and environmental factors may be associated with 
shorter sleep duration and obesity trends (Bennett, Probst, & Pumkam, 2011; Crosby, 
Wendel, Vanderpool, & Casey, 2012; Jones, Parker, Ahearn, & Jayachandran, 
2009;Whinnery et al. 2014). Additional examination of sleep in overweight and obese 
mid-life and older rural women is warranted as this population is underrepresented. 
In addition to obesity, self-reported short sleep duration and sleep disturbances 
have been associated with inflammation, cardiometabolic disease risk, and hypertension 
(Bansil, Kuklina, Merritt, & Yoon, 2011; Grandner, Sands-Lincoln, Pak, & Garland, 2013; 
Grandner, Jackson, Pak, & Gehrman, 2012).  The relationship of sleep with increased 
risk of cardiometabolic disease is particularly important in women due to high mortality 
rates from heart disease (Go et al., 2014). Women who self-reported short sleep 
duration of 6 hours or less per night had a greater risk of hypertension; obesity may 
potentiate this relationship (Gangwisch, Feskanich, Malaspina, Shen, & Forman, 2013; 
Guo et al., 2013). Pain also may have a significant relationship with sleep and weight 
status. A recent survey reported that adults who experienced pain slept less and had 
poorer sleep quality than those without pain (Knutson, 2015). In obese individuals, pain 
has been associated with chemical mediators and difficulty sleeping (Okifuji & Hare, 
2015). We are only aware of one study that found an association between self-reported 
sleep disturbance and pain in overweight and obese women (Wachholtz, Binks, Suzuki, 
& Eisenson, 2009). Closer observation may show that sleep could be associated with 
pain and health among rural women who are overweight or obese. 
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 Objectively measured short sleep duration was found to be associated with 
higher BMI and greater waist circumference in adults, but other studies reported these 
relationships were not maintained over time (Appelhans et al., 2013; Evans et al., 2011; 
Lauderdale et al. 2009; Mezick, Wing, & McCaffery, 2014; Moraes et al. 2013). The 
relationship between objectively measured sleep and weight status remains unclear. 
Further examination of the longitudinal relationship between sleep and obesity is 
needed.     
Sleep behavior has been reported to influence quality of life, body function and 
performance (Czeisler, 2015; Lee et al., 2009). Likewise, improving healthy behaviors 
may influence sleep and overall health. Alfaris et al. (2015) reported significantly higher 
self-reported sleep duration and sleep quality in obese men and women with 5% or more 
weight loss while enrolled in a behavioral weight loss intervention. A slightly different 
relationship was reported by Thomson et al. (2012); they found that higher self-reported 
sleep quality and quantity increased the likelihood of weight loss by 33% in overweight 
and obese women enrolled in a weight loss program. In contrast, moderate-intensity 
exercise, stretching, and behavioral weight loss programs have reduced BMI but did not 
significantly change sleep quality in adults (O’Brien et al., 2012; Tworoger et al., 2003). 
Weak associations were found between self-reported shorter time to fall asleep and 
weight loss (O'Brien et al., 2012). Additional evidence is needed to clarify the 
relationships between weight loss, sleep quality, duration and other health factors. The 
purpose of this paper is to describe self-reported and objective measurements of sleep 
and the relationships between sleep, pain, and demographic and health-related factors 
in overweight and obese mid-life and older rural women enrolled in a randomized 
controlled trial.  
The specific aims were to: 
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1) Characterize self-reported sleep disturbance, pain interference, and health-related 
factors. 
2) Describe objective indirect measurements of sleep.  
3) Observe relationships between sleep, pain, and health-related factors (total sample and 
in non-achievers and achievers of weight loss). 
4) Identify the predictors of change in self-reported sleep disturbance. 
Methods 
The “Women Weigh-In for Wellness” trial was designed to promote healthy 
eating, physical activity, and weight loss. The detailed protocol for the study has been 
published (Hageman, Pullen, Hertzog, Boeckner, & Walker, 2011). The randomized 
clinical trial was investigator-initiated and community-based and approved by the 
Institutional Review Board at a Midwestern US University. All participants provided 
written informed consent prior to study enrollment. The clinical trial evaluated the 
effectiveness of theory-based web-delivered interventions for promoting healthy eating 
and activity among mid-life and older rural women with the goal of achieving 5-10% 
weight loss and weight maintenance over a 30-month period. There were three arms of 
the intervention: interactive web site, interactive web site plus a peer -led discussion 
board, and interactive web site plus email counseling. An interactive web site was 
available to all women that provided weekly messages, opportunities to monitor and post 
goals, calories, fat grams, weight in pounds, and physical activity behaviors. 
Individualized feedback of the results of the assessment visits were posted online. At 
baseline and 6 months, actigraphy measurements were obtained as well as other 
behavioral, biomarker and anthropometric measurements. This secondary analysis 
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examined data at baseline, 6 months and the change over time. These times represent 
Phase 1, called the Weight Loss phase, of the 30 month study. 
Sample and Setting          
 A total of 301 overweight and obese mid-life and older rural women enrolled. 
Eligible individuals resided in large, small, or isolated rural areas as defined by Rural 
Urban Commuting Area (RUCA) codes (Hart & Casey, 2012). The women resided in one 
of 16 rural counties in a Midwestern state in the US (Hageman, Pullen, Hertzog, 
Boeckner, & Walker, 2011).  
Inclusion and Exclusion Criteria 
Women were included in the study if they: a) were 40-69 years of age; b) 
overweight or Class I & II obese (BMI 28 to 39.9) or BMI 40 to 45 with physician 
clearance; c) able to speak and read English; d) able to communicate over the 
telephone, e) made a commitment to lose weight through changing eating and physical 
activity behaviors; f) able to use a computer with minimal assistance to access the 
internet and complete electronic forms; g) made a commitment to access the website as 
required by the research intervention; h) had or were willing to obtain an email account; 
i) had access to a DVD player; j) able to walk without assistance (including cane, 
crutches, walker, oxygen); k) answered ‘no’ to all questions on the Physical Activity 
Readiness Questionnaire (PAR-Q) or obtained clearance from their physician to become 
more active and participate in the assessment of physical activity biomarkers (Cardinal, 
1997);  and l) resided within approximately 60-mile  radius of the research site in a 
Midwestern state. 
Women were excluded from participating if: a) diagnosed with Type 1 diabetes, 
b) diagnosed with Type 2 diabetes and required insulin, c) had a ≥10% weight loss in 
last 6 months; d) were currently enrolled in a weight loss management program; e) 
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taking medications that affect weight loss or weight gain; f) enrolled in or undergoing a 
formal program of cardiac rehabilitation; and g) other physical or medical restrictions that 
would preclude following the minimum recommendations for moderate physical activity 
and healthy eating. 
Measurements    
 Demographic/Anthropometric/Biomarkers. Assessments were gathered using 
reliable and valid measures. Demographic and health history data were obtained via an 
investigator developed questionnaire. Age and menopausal status were measured by 
self-report items on the health history questionnaire. Participants were asked “Have you 
gone through menopause?” and “If yes, at what age did you go through menopause?”  
We also collected anthropometric measurements. Height and weight were collected 
using The Tanita Model Composition Analyzer, Scale, Printer & Height Rod [TBF-215, 
Tanita Corporation of America, Inc.]. Prior to assessment, women fasted, refrained from 
exercise, alcohol use, and voided. BMI was calculated as weight in kilograms divided by 
height in meters-squared. A weight loss of 5% or more represents a significant change 
of weight (Wing, Lang, Wadden, Safford, 2011). Participants who did not achieve weight 
loss of at least 5% or more were considered non-achievers, and those who did were 
achievers. Waist circumference was measured in inches by placing a snug tape in a 
horizontal plane around the abdomen at the level of the iliac crest at the end of 
expiration; the average of two measurements was recorded (US Department of Health 
and Human Services, 1998).   
Blood pressure was collected using the e-sphyg 2 [9002] Automatic 
Sphygmanometer [American Diagnostic Corporation, Hauppauge, NY].  The women did 
not consume caffeine or participate in exercise or smoking prior to blood pressure 
assessment. Blood pressure was assessed using standard technique after 5 minutes of 
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quiet sitting (Perloff et al., 1993). A minimum of two blood pressure measurements 
separated by at least 30 seconds were obtained. Systolic and diastolic blood pressures 
were recorded as the mean of the two measurements within 5 mmHg (Perloff et al., 
1993). 
Self-reported Sleep Disturbance and Pain Interference. Self-reported sleep 
disturbance and pain interference were each measured from the respective four item 
subscale of the Patient Reported Outcomes Measurement System (PROMIS-29v1.0) 
and interpreted from participants’ T-scores based on general population norms. A T-
score of 50 represents the mean score in the general population and a higher PROMIS 
T-score represents poorer sleep or more pain interference (Gershon, Rothrock, 
Hanrahan, Bass, & Cella, 2010). Sleep disturbance items assessed the participant’s self-
reported perceptions of sleep quality, depth, and restoration over 7 days. The 
measurement included five-point Likert-style choices (ranging from very poor to very 
good) in response to the participant’s sleep quality, if sleep was refreshing, difficulty 
falling asleep, as well as problems with sleep (Gershon, Rothrock, Hanrahan, Bass, & 
Cella, 2010). The PROMIS sleep disturbance subscale demonstrated an alpha reliability 
of 0.87 at baseline and 6 months.  
Four self-reported pain interference subscale items measured self-reported 
consequences of pain and the extent of how pain hinders engagement in all activities 
over 7 days. The measurement included five-point Likert-style choices (ranging from not 
at all to very much) in response to the participant’s pain interference with activities 
(Gershon et al., 2010). The PROMIS pain interference subscale demonstrated an alpha 
reliability of 0.93 at baseline and 0.97 at 6 months.  
Objective Indirect Sleep. The ActiGraph wGT3X [ActiGraph, Pensacola, FL] 
was used to collect indirect measurements of 24-hour sleep/wake patterns. Women 
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were instructed on proper wear of the ActiGraph and wore it for 24-hours a day. Women 
completed a sleep diary that was used to identify bedtime and out-of-bed times during 
analysis. Most studies measure objective sleep parameters by wrist-worn actigraphy; 
this study used hip-worn placement.  
An addendum study was implemented on a sub-sample of 26 participants who 
were recruited to compare sleep parameter measurements using wrist and hip 
actigraphy. Results indicated mostly reliable and correlated measures between the sites. 
High correlations were found for three variables (TST, WASO, and percent awake) 
between wrist and hip measures (r= 0.93, 0.85, and 0.87 respectively); but not for 
number of awakenings (r= .39, p=.083). As illustrated in Figure 1, the actigraph monitor 
was worn on the dominant hip. We examined four objective sleep parameters: total 
sleep time (TST), number of awakenings, wake after sleep onset (WASO), and percent 
sleep. The TST is the number of minutes of actual sleep while in bed and the number of 
awakenings is the number of wake counts after the onset of sleep. The WASO minutes 
are the amount of time spent awake after sleep has begun. Percent sleep is the ratio of 
TST to the amount of time spent in bed. Normal values are considered 7-9 hours for 
TST, less than 6 number of awakenings, less than 30 minutes for WASO, and a percent 
sleep of 85% or higher. Values not within normal limits may indicate sleep disturbance 
(Berger et al., 2005).  
Data Analysis  
 As shown in the consort diagram, we were unable to use data from 32 
participants due to attrition and 48 participants due to lack of actigraphy data. A 
minimum number of 4 nights of wear were required for analyzing sleep/wake data. We 
compared the baseline data of the 80 women without actigraphy data with the 221 
women in the analysis and found no significant differences between study variables. We 
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analyzed n=221 participants who had 4 nights of actigraphy measurements, complete 
sleep diaries and PROMIS questionnaires at baseline and 6 months.  
Descriptive statistics were used for aims 1 and 2 to determine the mean, range, 
percent, and standard deviations of demographic, anthropometric, and biomarker 
variables at baseline and 6 months. The change variable from baseline to 6 months was 
calculated for weight, BMI, waist circumference, and blood pressures such that an 
increase in those variables is represented positively and a decrease is represented 
negatively. Pearson correlations were used for aims 3 and 4 to examine the associations 
between study variables. Weight loss was treated as a single dichotomous variable with 
non-achievers being labeled 0 and achievers labelled as 1. A two-tailed level of 
significance of p= .01 was used to examine the relationships between non-achievers and 
achievers of weight loss. Due to the exploratory nature of this study, the use of a 
stringent p value may conceal potential relationships that merit further study. Multiple 
linear regression modeling was used in aim 4 on the change scores to determine if 
specific factors contributed to a meaningful amount of influence on self-reported sleep 
disturbance. Our primary predictors were weight change and pain interference; and we 
controlled for age and arthritis because they were potential confounders. This was done 
to determine if weight change had a meaningful influence on self-reported sleep 
disturbance. A two-tailed level of significance was designated at p= .05. SPSS v22 
statistical software package was used. 
Results 
Baseline Characteristics 
Baseline characteristics are shown in Table 1. Of the participants 97% were 
Caucasian and 84% married; 43% had completed some college; 68% were employed 
full-time, and over 90% had health insurance. The mean age was 54.5 years and most 
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women were post-menopausal. The self-reported sleep disturbance score and 
actigraphy measurements reflected normal sleep characteristics. Pain interference 
scores were slightly higher than normal.  
Characteristics: Overall and in Non-Achievers and Achievers   
 Characteristics at 6 months and the change over time of the 221 women are 
displayed in Table 2. The self-reported sleep disturbance scores, pain interference 
scores, and actigraphy variables did not change considerably, but the anthropometric 
and biomarker variables decreased from baseline to 6 months. Table 2 also shows 
characteristics and significant changes in women who were non-achievers (53%) and 
achievers (47%) of 5% or more weight loss.  
Overall Relationships at Baseline, 6-Months, and Change Scores in the Total 
Sample 
Significant relationships were found at baseline. Higher self-reported sleep 
disturbance scores were associated only with higher pain interference scores (r= .252, 
p<.05). We also found associations between the higher pain interference score and 
higher weight (r= .214, p<.05) and BMI (r= .218, p<.05). Objectively measured sleep was 
not associated with any other study variables.  
Table 3 shows the relationships of the variables at 6 months. Weak associations 
were found between higher self-reported sleep disturbance scores and higher blood 
pressures. Higher sleep disturbance was moderately associated with higher pain 
interference scores. Pain interference scores were associated with most of the 
anthropometric and biomarker variables. Higher pain interference scores had weak to 
moderate associations with older age, higher weight, BMI, waist circumference, and 
systolic, but not diastolic blood pressure. Relationships also were found between 
objective sleep variables. Weak associations were observed between higher objective 
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WASO minutes and higher pain interference scores. Higher WASO minutes and number 
of awakenings were associated with higher BMI and blood pressure. Lower percent 
sleep had weak associations with higher weight, BMI, and pain interference scores.  
We observed relationships between change scores in self-reported sleep 
disturbance and pain interference and the change in anthropometric and biomarker 
measures. There were weak positive associations between the change in self-reported 
sleep disturbance score and change in weight (r=.202, p<.05), BMI (r=.211, p<.05), waist 
circumference (r= .169, p<.05), and diastolic blood pressure (r= .137, p<.05). Positive 
associations also were found between the change in pain interference scores and 
several of the same variables including change in weight (r= .185, p<.05), BMI (r= .205, 
p<.05), waist circumference (r =.153, p<.05), and systolic blood pressure (r=.152, p<.05).  
Next, we evaluated the relationships between the change scores in objective 
sleep measurements and the change in anthropometric and biomarker measures. 
Change in total sleep time was not associated with either the change in BMI or weight. 
Weak positive associations were found between the number of awakenings per 
actigraphy and changes in weight (r= .167, p<.05), BMI (r= .171, p<.05), waist 
circumference (r= .173, p<.05), and both systolic (r= .175, p<.05) and diastolic (r= .208, 
p<.05) blood pressures.  
 Relationships among Non-Achievers and Achievers of 5% Weight Loss 
  Table 4 shows the relationships in non-achievers and achievers at 6 months. In 
non-achievers, higher self-reported sleep disturbance and self-reported sleep quality 
scores were moderately positively associated with higher pain scores. We also found 
that higher pain interference scores had a weak association with higher WASO minutes.  
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In achievers, we found weak associations between lower self-reported sleep 
quality and disturbance scores and lower pain interference scores. Several weak to 
moderate associations were observed between lower pain interference scores and 
weight loss, and smaller waist circumference. Objectively measured lower WASO 
minutes, number of awakenings, and higher sleep percent had weak associations with 
lower BMI. Achievers also demonstrated weak relationships between higher objectively 
measured percent sleep and weight loss.    
A regression model was fit to predict lower self-reported sleep disturbance 
scores. Table 5 shows higher weight loss and lower pain interference as significant 
predictors of lower self-reported sleep disturbance at 6 months. Approximately 6% of the 
variance in the change in self-reported sleep disturbance was accounted for by the 
change in pain interference, weight, age, and arthritis. Age and arthritis were non-
significant predictors of change in self-reported sleep disturbance when holding constant 
change in weight and pain interference. Both change in weight and change in pain 
interference had similar importance to the model. For every pound lost, a corresponding 
drop of 0.163 was seen in the self-reported sleep disturbance score when holding 
constant age, arthritis, and change in pain. In addition, for every one unit drop in pain 
interference, a corresponding drop of 0.142 was seen in the self-reported sleep 
disturbance score when holding constant age, arthritis, and change in weight.  
Discussion 
This secondary analysis describes self-reported and objective sleep and their 
relationships with health-related factors in 221 mid-life, overweight and obese rural 
women who participated in the “Women Weigh-In for Wellness” clinical trial. This is the 
first known report of concurrent self-reported and objective measurement of sleep 
parameters in healthy, mid-life, overweight and obese rural women. We will now discuss 
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these findings in relationship to each specific aim and provide implications for research 
and practice.  
Women self-reported sleep disturbance similar to norms and self-reported higher 
pain interference. While the women did not have high sleep disturbance, our findings 
were complementary to previous reports of overweight or obese women exhibiting pain 
(Wachholtz et al., 2009).  Overall, women were not hypertensive according to the current 
JNC-8 guidelines (James et al., 2014). Aside from being overweight and obese, women 
had fairly normal self-reported sleep, pain, and biomarker characteristics. “The Women 
Weigh-in for Wellness” trial may have had a positive influence on health-related 
characteristics by lowering weight, BMI, waist circumference, and blood pressures in 
some women. 
We were surprised to find that the objective indirect measurements of sleep 
reflected very good sleep at baseline and 6 months. There was not much room for 
improvement of sleep duration; actigraphy results revealed that over 7 days, women 
were sleeping a mean duration of over 7 ½ hours. The sleep duration was in accordance 
with current recommendations. Women in our sample were mid-life and older, with the 
majority employed. These women may have had scheduled day activities and 
maintained regular sleep habits. Also, a ceiling effect could have occurred in the indirect 
measurement of sleep. Prior studies collected longitudinal data over years whereas this 
study included data at baseline and 6 months. Considering data from 30 months was not 
yet available, we are unable to project if the women will maintain good sleep duration.  
Overall, we found consistent relationships among higher self-reported sleep 
disturbance with higher pain interference. Pain interference was revealed to be a 
noteworthy variable as it also was associated with multiple anthropometric, biomarker 
and ultimately objective indirect sleep variables. Pain could be associated with sleep 
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because these centers may have reciprocal relationships within the brain (Moldofsky, 
2001). Women who suffer from disturbed sleep may report pain, and those who have 
pain may report disturbed sleep (Finan, Goodin, & Smith, 2013).  
Previous studies also reported associations between self-reported sleep duration 
and BMI or weight (Di Milia et al., 2013; Kohatsu et al., 2006; St-Onge et al., 2010; 
Theorell-Haglow et al., 2012). Although we did not measure self-reported sleep duration, 
we found higher self-reported sleep disturbance was associated with higher blood 
pressures (Bansil, Kuklina, Merritt, & Yoon, 2011;Fang et al., 2012; Grandner, Jackson, 
Pak, & Gehrman, 2012; Guo et al., 2013). Our findings are consistent with several 
studies that did not support the immediate or longitudinal relationship between 
objectively measured short sleep duration and higher BMI or weight (Appelhans et al., 
2013; Evans et al. 2011; Lauderdale et al., 2009; Mezick et al., 2014; Moraes et al., 
2013). Over the 6 months, change scores reflected improved sleep and pain that were 
associated with lower weight, BMI, waist circumference, and blood pressure.  
Women who achieved 5% or more weight loss had improved sleep, pain 
interference, and blood pressure. Our analysis adds to the evidence supporting the 
association of better self-reported sleep quality and duration with weight loss (Alfaris et 
al., 2015; O'Brien et al., 2012; Thomson et al. 2012). Weight loss and lower pain 
interference were predictors of lower self-reported sleep disturbance. Weight loss could 
lower pain and contribute to less disruption in sleep. Women with less sleep disruption 
may sequentially show lower blood pressure. These results support the relationship 
between sleep and weight change; sleep may be a factor in achieving weight loss, or 
vice versa. Thus, it is important for obese or overweight women to adopt healthy sleep, 
diet, and physical activity to improve or maintain health status. 
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There were strengths of this secondary analysis. This was the first study to 
examine self-reported sleep and objective indirect measurement of sleep duration and 
its association with health factors in healthy obese and overweight mid-life and older 
rural women. The parent study used reliable and valid instruments. Our secondary 
analysis assessed both self-reported sleep disturbance with the PROMIS and an 
objective indirect measurement of sleep.  
Our analysis is not without limitations. Even though this analysis included data 
from 73% of the original sample; selection bias could have occurred. The main limitation 
of this study was the positioning of the actigraph on the hip. Zinkhan et al. (2014)  
recently reported differences in agreement between hip-worn actigraph, 
polysomnogram, and the wrist-worn device. This limitation affects validity of the results 
using number of awakenings and comparison to other studies using wrist actigraphy. 
Women were not screened for diagnoses of sleep apnea or other sleep disorders. 
Obesity is a risk-factor for obstructive sleep apnea and can result in sleep disturbance 
(Knutson, Zhao, Mattingly, Galli, & Cizza, 2012). Weight loss may not improve sleep if a 
sleep disorder is present. Medications were not recorded; however women were 
excluded if they took medications that influenced weight. This study did not collect a 
medication history to confirm the use of medications that influence sleep. 
Conclusion 
Sleep quantity and quality influence health. This secondary analysis was 
performed to provide a description of sleep and its association with health factors in a 
sample of rural overweight and obese mid-life and older women. The results are 
promising support for interventions aimed at communities to improve health and sleep 
behaviors.  
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Grandner (2012) suggests that the science of sleep could benefit from 
interventions that are clearly conceptualized and performed at the community level. 
Other research implications include the need for consistent use of reliable and valid self-
reported and objective measures of sleep quality and duration. Studies need to confirm 
the norms for sleep variables per actigraphy in mid-life and older women. Self-reported 
sleep is often over or under-estimated and data collected in epidemiological studies may 
not correspond to objective indirect measures of sleep using actigraphy (Girschik, 
Fritschi, Heyworth, & Waters, 2012). Self-reported sleep duration has shown negative 
agreement with objectively measured sleep/wake parameters (Girschik et al., 2012).  We 
observed that self-reported sleep disturbance was not significantly correlated with 
objectively measured sleep. Self-report quality measures complement, but are not 
equivalent to quantify actigraphy parameters such as sleep duration (total sleep time), 
WASO, and number of awakenings. Thus, examining sleep quantity, quality, and 
disturbance using self-reported and objective measures is recommended (Grandner, 
2012; Madsen, Huang, & Gogenur, 2015). Measuring sleep by both methods provides a 
well-rounded depiction of sleep’s association with being overweight or obese and with 
weight loss or gain. Science could benefit from more studies of mid-life and older women 
living in rural and small communities and specifically target ethnicities other than 
Caucasian in which obesity/overweight and hypertension are prevalent. Intervention 
studies are needed that specifically focus on the impact of weight loss on sleep and 
pain.  
Health professionals need to translate research evidence on sleep into practice. 
Implications for practice include screening, assessment, and management of sleep 
disorders and disturbances, pain, and blood pressure in overweight and obese women. 
Health professionals need to educate and encourage non-pharmacologic and/or 
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pharmacologic management of sleep disturbances and pain as indicated. Clinicians 
need to encourage and monitor healthy lifestyle behaviors, paying particular attention to 
evidence based strategies appropriate for rural women to promote weight loss through 
healthy eating, physical activity, and sleep.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All procedures followed were in accordance with the ethical standards of the responsible 
committee on human experimentation (institutional and national) and with the Helsinki 
Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients 
for being included in the study. 
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Figure 1. Hip-worn actigraphy   
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Figure 2.    Consort Diagram 
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Table 1  
Sleep, Pain, and Anthropometric, Biomarker, Characteristics as Measured by Self-report (PROMIS) and Actigraphy at Baseline 
(N=301) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Note: A= Actigraph, S= Self-report 
 Note: no significant differences were found between groups  
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable  
        N 
Baseline Data 
Secondary Analysis 
N = 221 
 Baseline Data 
Not in Secondary Analysis 
N= 80 
M (SD) N M(SD) 
Sleep Disturbance Score (S) 221 49.0 (7.2) 80 48.9 (6.8) 
Pain Interference Score (S) 220 51.6 (7.2) 80 54.1 (7.3) 
Total Sleep Time (A) 221 455.1 (42.8) 80 458.9 (44.5) 
Wake After Sleep Onset (A) 221 17.5 (10.2) 80 22.6 (12.8) 
Number of Awakenings (A) 221 4.8 (2.2) 80 5.9 (2.8) 
% Sleep (A) 221 96.3% (2.1) 80 94.9% (2.4) 
Age (years) 221 54.5 (7.0) 80 52.3 (6.2) 
Weight (lbs) 221 205.4 (28.7) 80 210.4 (28.8) 
Body Mass Index 221 34.6 (4.2) 80 35.4 (4.2) 
Waist Circumference (inches) 221 42.8 (4.3) 80 42.9 (4.3) 
Arthritis 221 27.6%  80 23.8%  
Systolic BP 221 123.1 (11.8) 80 123.0 (12.5) 
Diastolic BP 221 76.9 (7.8) 80 76.4 (8.2) 
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Table 2 Sleep, Pain, and Anthropometric, Biomarker Characteristics as Measured by Self-report (PROMIS) and Actigraphy at 6 Months, and Change Over Time 
(N=221) 
Note: A= Actigraph, S= Self-report
 
a 
Denotes significant changes between Non-achievers and Achievers from baseline to 6 months; *Denotes that participant did not answer a pain item. 
 
 
 
 
 
 
  
Variable 
N 
6-months 
N 
Base to 6 
Months Change 
 
 
Base to 6 Month 
Change in 
Non-Achievers  
Base to 6 Month 
Change in 
Achievers 
 M(SD) M(SD)  N M (SD) N M (SD) 
Sleep Disturbance Score (S)
a 
220 48.8 (6.9) 220 -0.2 (6.3)  117 1.3 (6.4) 103 -1.9 (5.8) 
Pain Interference Score (S)
a 
220 51.7 (8.5) 219 0.1 (7.4)   116
* 
1.4 (7.2) 103 -1.3 (7.3) 
Total Sleep Time (A) 221 457.3 (43.6) 221 2.2 (38.2)  118 4.0 (37.8) 103 0.4 (38.9) 
Wake After Sleep Onset (A) 221 17.1 (10.1) 221 -0.4 (11.4)  118 0.4 (12.3) 103 -1.2 (10.2) 
Number of Awakenings (A) 221 4.5 (2.3) 221 -0.3 (2.1)  118 0.1 (2.3) 103 -0.8 (1.9) 
% Sleep (A) 221 96.4% (2.0) 221 0.7% (2.3)  118 0.0 (2.5) 103 0.2 (2.1) 
Weight (lbs)
a 
221 193.7 (31.5) 221 -11.7 (13.3)  118 -1.9 (5.6) 103 -22.95 (10.3) 
Body Mass Index
a 
221 32.6 (4.8) 221 -2.0 (2.2)  118 -0.3 (0.9) 103 -3.8 (1.6) 
Waist Circumference (inches)
a 
221 40.4 (4.7) 221 -2.4 (2.9)  118 -0.8 (2.3) 103 -4.2 (2.3) 
Systolic BP
a 
221 120.4 (13.6) 221 -2.7 (11.2)  118  0.9 (9.6) 103 -6.9 (11.2) 
Diastolic BP
a 
221 75.6 (4.8) 221 -1.2 (6.4)  118 1.3 (5.4) 103 -4.0 (6.3) 
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Table 3 Correlations between Sleep, Pain, Anthropometric, and Biomarker Variables at 6 Months (N=221) 
Variable Age Weight Body Mass 
Index 
Waist 
Circumference 
Systolic BP Diastolic 
BP 
Pain 
Interference 
Sleep Quality (S) .109 -.124 -.105 -.087 -.111 -.141* -.347** 
Sleep Disturbance Score (S) -.050 .099 .080 .087 .136* .139* .434** 
Pain Interference Score (S) .147* .260** .228** .258** .166* .054 - 
Total Sleep Time (A) .030 -.029 -.044 -.011 .050 .060 .062 
Wake After Sleep Onset (A) .033 .126 .168* .095 .142* .099 .146* 
Number of Awakenings (A) .073 .122 .177** .110 .167* .150* .113 
% Sleep (A) -.029 -.135* -.172* -.106 -.125 -.075 -.140* 
Age - -.098 -.070 .014 .069 -.147* .147* 
Weight (lbs.) -.098 - .871** .846** .334** .288** .260** 
Body Mass Index -.070 .871** - .814** .339** .317** .228** 
Systolic BP .069 .334** .339** .257** - .689** .166* 
Diastolic BP -.147* .288** .317** .276** .689** - .054 
Note: A= Actigraph, S= Self-report; *p<.05 (2-tailed), **p<.01 (2-tailed) 
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Table 4 Correlations between Sleep, Pain, Anthropometric, and Biomarker Variables in Non-Achievers (n=118) and Achievers (n=103) at 6 
Months 
Variable Age Weight Body Mass Index Waist Circumference Systolic BP Diastolic BP Pain Interference 
 
Non-
Achiever Achiever 
Non-
Achiever 
Achiever Non-
Achiever 
Achiever Non-
Achiever 
Achiever Non-
Achiever 
Achiever Non- 
Achiever 
Achiever Non- 
Achiever 
Achiever 
Sleep Quality 
(S) 0.073 0.168 
 
-015 
 
-.207 
 
-.054 
 
-.101 
 
.041 
 
-.173 
 
-.103 
 
-.082 
 
-.193 
 
-.032 
 
-.340** 
 
-.339** 
Sleep 
Disturbance 
Score (S) -0.027 -0.094 
 
 
.016 
 
 
.105 
 
 
.029 
 
 
.029 
 
 
-.002 
 
 
.089 
 
 
.155 
 
 
.057 
 
 
.187 
 
 
.019 
 
 
.462** 
 
 
.371** 
Pain 
Interference 
Score (S) .188 0.085 
 
 
.184 
 
 
.263** 
 
 
.155 
 
 
.212 
 
 
.129 
 
 
.315** 
 
 
.173 
 
 
.090 
 
 
.042 
 
 
-.011 
 
 
- 
 
 
- 
Total Sleep 
Time (A) 0.04 0.014 
 
-.010 
 
-.120 
 
-.111 
 
-.051 
 
.015 
 
-.100 
 
.078 
 
-.009 
 
.086 
 
.004 
 
.145 
 
-.055 
Wake After 
Sleep Onset 
(A) 0.104 -0.057 
 
 
.020 
 
 
.216 
 
 
.071 
 
 
.261** 
 
 
.009 
 
 
.140 
 
 
.165 
 
 
.091 
 
 
.099 
 
 
.071 
 
 
.244** 
 
 
.009 
Number of 
Awakenings 
(A) 0.141 -0.018 
 
 
.017 
 
 
.150 
 
 
.038 
 
 
.258** 
 
 
-.016 
 
 
.145 
 
 
.195 
 
 
.081 
 
 
.157 
 
 
.085 
 
 
.197 
 
 
-.031 
% Sleep (A) -0.099 0.054 
 
-.017 
 
-.248** 
 
-.078 
 
-.270** 
 
-.008 
 
-.176 
 
-.139 
 
-.090 
 
-.064 
 
-.063 
 
-.218 
 
-.038 
Age - - 
 
-.096 
 
-.166 
 
-.096 
 
-.104 
 
-.005 
 
-.009 
 
.066 
 
.054 
 
-.206 
 
-.110 
 
.188 
 
.085 
Weight (lbs) -0.096 -0.166 
 
- 
 
- 
 
.811** 
 
.863** 
 
.736** 
 
.880** 
 
.339** 
 
.168 
 
.270** 
 
.131 
 
.184 
 
.263** 
Body Mass 
Index -0.096 -0.104 
 
.811** 
 
.863** 
 
- 
 
- 
 
.681** 
 
.842** 
 
.346** 
 
.165 
 
.325** 
 
.129 
 
.155 
 
.212 
Systolic BP 0.066 0.054 .339** .168 .346** .165 .217 .118 - - .650** .695** .173 .090 
Diastolic BP -.206 -0.11 
 
.270** 
 
.131 
 
.325** 
 
.129 
 
.239** 
 
.137 
 
.650** 
 
.695** 
 
- 
 
- 
 
.042 
 
-.011 
Note: A= Actigraph, S= Self-report **p<.01 (2-tailed) due to potential collinearity (SP) between variables  
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Table 5 Ordinary Least Squares Regression Predicting Change from Baseline to 6 Months in Self-reported Sleep Disturbance 
(PROMIS) (N=221) 
Predictor Variables Unstandardized 
B 
Standardized β 
Coefficient 
  
t 
Age (baseline) -.045               -.051                    - .719  
Arthritis (baseline) -1.068 -.078  -1.089 
Weight Change  .163  .173   2.489* 
Pain Interference Change  .142                .171                     2.476*  
Adjusted R
2 
= .061, F(4, 214) = 4.316 p=0.002 
*p<.05 (2-tailed) 
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Abstract 
 Taking potentially inappropriate medications (PIMs) is a serious public health 
problem in older adults. The use of PIMs may lead to adverse events and increased 
health costs. The purpose of this study was to explore the prevalence, characteristics, 
and factors associated with the use of PIMs in rural, community-dwelling older adults. 
Participants (N=138) underwent one-on-one reviews of all prescribed and over-the-
counter medications, vitamins, and supplements. The 2012 Beers Criteria were used to 
record PIMs to avoid. Data were collected on participants’ demographics, subjective 
physical and mental health, sleep, and objective sleep-wake patterns. Almost half (49%) 
of the sample used both prescribed and over-the-counter (OTC) PIMs in the past month. 
Prescribed and OTC non-steroidal anti-inflammatory drugs (33%) and medications with 
anticholinergic properties (28%) were the most frequently used PIMs taken by 
participants. The participants also took short-acting benzodiazepines. The use of PIMs 
was associated with higher number of medications (r=0.331, p<0.01), more medical 
providers (r=0.223, p<0.001) and poor physical health (r=-0.193, p<0.05). More 
medications was the only significant predictor of an increased probability of the use of 
PIMs, OR 1.8, 95% CI [1.19, 2.84]. Results highlight the importance of monitoring 
community-dwelling older adults taking multiple medications because they may be taking 
PIMs. As primary health provider shortages loom in rural areas, interventions need to 
include health care team collaboration to systematically reduce the prescribing and OTC 
use of PIMs. 
 
Keywords: Rural, Older adults, Medications, Sleep, Actigraphy 
Introduction 
Older adults are at risk for using potentially inappropriate medications (PIMs) 
(Weng et al., 2013). A PIM is any pharmaceutical product, prescription or over-the-
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counter (OTC) that has been determined to have risks that outweigh benefits (Beers, 
1997). PIMs use has been studied over two decades in terms of health provider 
prescribing patterns. The use of PIMs has been associated with adverse drug events 
(ADEs), defined as any injury resulting from a pharmacological medical intervention. An 
ADE can be comprised of medical errors, adverse drug reactions, allergic reactions, and 
overdoses (Institute of Medicine, 2007; Kohn, Corrigan, & Donaldson, 2000).   
An estimated 42.6% of community-dwelling older adults are prescribed PIMs, the 
most frequent being non-steroidal anti-inflammatory drugs (NSAIDS) and anticholinergic 
medications (Davidoff et al., 2015; Kachru, Carnahan, Johnson, & Aparasu, 2015). The 
use of 5 or more medications has been reported to increase the risk of taking PIMs and 
several PIMs can be purchased OTC without health care provider prescription or 
knowledge (Maher, Hanlon, & Hajjar, 2014). 
The Beers Criteria is an example of a resource derived from scientific evidence 
associating PIMs use with the risk of negative health outcomes. The 2012 Beers Criteria 
lists 53 medications or medication classes that are divided into three categories: 
recommended medications and classes to avoid in older adults, medications and 
classes to avoid in older adults with certain diseases, and finally medications to be used 
with caution in older adults (American Geriatrics Society 2012 Beers Criteria Update 
Expert Panel, 2012). 
Older age (65 and older), female gender, and the use of a higher number of 
medications have been associated with PIMs use (Guaraldo, Cano, Damasceno, & 
Rozenfeld, 2011). Among rural older adults, Blalock and colleagues, (2005) found that 
greater medication needs, lower social support, higher levels of disability, and being 
diagnosed with chronic conditions such as osteoarthritis were associated with greater 
PIMs use. The use of PIMs in rural communities (population less than 50,000) also was 
associated with a lack of geriatric care providers (Blalock et al., 2005; Dall et al., 2013; 
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National Conference of State Legislatures, 2013). In community-dwelling older adults, 
the likelihood of the use of potentially inappropriate anticholinergic medications was 
increased in females, those residing in southern states, and the presence of an anxiety 
disorder (Kachru et al., 2015). Health care providers may not be aware of their patients 
OTC drug use at home (Chui, Stone, Martin, Croes, & Thorpe, 2014; Torrible & Hogan, 
1997). Factors such as these could lead to inappropriate management of medications 
and chronic diseases in rural settings. 
In the U.S., older adults comprise 18% of residents in rural counties versus 12% 
in urban settings. The age distribution of counties has a tendency to get older along with 
rural (National Rural Health Association, 2014; NORC Walsh Center for Rural Health 
Analysis, 2014). Special attention should be given to the health of older adults living in 
rural areas. In Nebraska, one-third of residents live in rural counties and an estimated 
34% of inhabitants of rural counties are 60 years and older (Department of Health and 
Human Services DHHS, 2015). In comparison to urban settings, older adults in rural 
settings have higher rates of chronic illness, poorer overall health, and less access to 
care (National Conference of State Legislatures, 2013; National Rural Health 
Association, 2014).  
The health experience of rural dwelling older adults is manifested by multiple co-
morbidities, managing symptoms of disease, and seeking health care from multiple 
providers (Arcury et al., 2012). Rural dwelling older adults rest, reduce activities, and 
take OTC medicine to manage co-morbidities and symptoms of disease (Arcury et al., 
2012). Pain may promote the use of prescribed or OTC non-opioid medications. An 
Australian study reported the mean length of duration of prescribed treatment of pain 
with non-steroidal anti-inflammatory drugs (NSAIDs) was almost 5 years (Gnjidic et al., 
2014). Long-term use of prescribed or OTC NSAIDs is potentially inappropriate and 
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needs to be carefully considered and monitored in older adults (Barkin et al., 2010; 
Findley & Bulloch, 2015; Gnjidic et al., 2014). 
The use of PIMs in older adults may be associated with poorer physical and/or 
mental health status. U.S. older adults who used inappropriate prescription medications 
were more likely to report poorer health status than those not using PIMs (Fu, Liu, & 
Christensen, 2004). Use of PIMs also was common in a sample of community-dwelling 
older adults with perceived depressive symptoms in New Zealand (Lee et al., 2013).  
Approximately 50% of older adults experience sleep-wake disturbances that are 
associated with factors such as pain or medication use for chronic illness (Ancoli-Israel, 
2009; Foral, Knezevich, Dewan, & Malesker, 2011; Martin, Tamblyn, Ahmed, & 
Tannenbaum, 2013). Sleep quality and sleep-wake disturbances are often overlooked in 
association with health status and older adults do not routinely report sleep problems to 
their providers (Ancoli-Israel, 2009; McCall, 2004; Ohayon, 2002).  
Some individuals seek sedative-hypnotics from primary care providers and 
others self-medicate with alcohol or OTC sleep aids with or without the knowledge of a 
health care provider (Basu, Dodge, Stoehr, & Ganguli, 2003). Sleep problems have been 
associated with the use of medications that promote sedation, have anticholinergic 
properties, and are potentially inappropriate for older adults (Ancoli-Israel, 2005; Ancoli-
Israel, 2009; Lee et al., 2013; Radcliff et al., 2015; Steinman, Handler, Gurwitz, Schiff, & 
Covinsky, 2011). Medications for insomnia are more likely to be used by older adults 
with high income and who take other medications with sedative effects (Bertisch, Herzig, 
Winkelman, & Buettner, 2014). Self-reported physical and/or mental health and sleep 
have not been routinely explored as factors associated with the use of PIMs. 
Therefore, the purpose of this study was to explore the use of, along with the 
factors associated with, the use of PIMs in rural community-dwelling older adults ≥ 65 
years old. The specific aims were to 1) Describe the use of PIMs to avoid and 2) Explore 
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individual demographic characteristics (age, gender, income, education, and rural home 
location), health experience (comorbidity, number of medications and health providers), 
and health status factors (physical and mental function, sleep disturbance, sleep quality, 
and 24 hours sleep-wake patterns) as predictors of use of PIMs to avoid. 
Methods 
Design and Conceptual Framework 
 This study used an exploratory descriptive study design. A derivative of Cox’s 
Interaction Model of Client Health Behavior (IMCHB) guided the study (Cox, 1982). 
Cox’s IMCHB is a middle range nursing theory that characterizes interactions that occur 
between client singularity, client-professional interaction, and health outcomes. Figure 1 
displays how the IMCHB was adapted for this study. The model included concepts that 
examined the relationships between client singularity variables and a single health 
outcome. 
Sample/Setting 
 A convenience sample of older adults was recruited from a rural family practice 
clinic in the Midwest. The rural setting was determined according to rural urban 
commuting area (RUCA) codes 7 and 10. Participants were screened according to 
inclusion and exclusion criteria. Inclusion criteria: males and females ≥ 65 years of age; 
taking ≥ 3 prescribed medications, living independently in the community, responsible for 
personal medication regimen, able to physically complete questionnaires, read and 
speak English, not taking medications for cognitive impairment, and scoring ≥ 26 on the 
Montreal Cognitive Assessment (MOCA) (Nasreddine et al., 2005). 
Measurements 
 Demographic Characteristics. Demographic data included age, gender, 
education, zip code, marital status, and household income. 
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 Health Experience. Participants were asked about the number of medications 
taken as well as their current number of health providers. Medications taken in the last 
month included: prescribed, OTC, herbal, vitamin, and supplements. Names of drugs, 
dosage, frequency, and length of use were verified with patient records. Additional 
information such as routine for taking medications and pharmacies were recorded. 
Medical diagnoses were recorded from each participant’s medical records. The Charlson 
Comorbidity Index was used to assess comorbidity (Charlson, Pompei, Ales, & 
MacKenzie, 1987). The index is weighted and takes into account the number and the 
seriousness of comorbid diseases and age. Comorbidities are associated with the risk of 
dying. Scores are assigned for each condition and the age of the individual, and then 
summed to predict mortality. In the original index 19 conditions were included that are 
scored from 1 through 6; additional points are added for age with 1 point for each 
decade over the age of 40. (Charlson, Szatrowski, Peterson, & Gold, 1994). Higher 
scores are indicative of higher severity of comorbidity. The index has established validity 
(Deyo, Cherkin, & Ciol, 1992).   
Health Status. The 12-Item Medical Outcomes Survey (MOS) Short Form (SF-
12) was developed to describe patient-reported physical and mental health status and to 
measure health related quality of life (QOL). The SF-12 is a comprehensive and shorter 
version of the SF-36 that measures physical and mental component scores (PCS and 
MCS). SF-12 summary scores (PCS and MCS) range from 0 to 100 and higher scores 
indicate better health. Age may influence norms and scores in those 65 and older have 
been reported as a PCS of 43.4 and MCS of 55.2 (Ware, Kosinski, & Keller, 1996). The 
tool has established reliability and validity in the older adult (Cernin, Cresci, Jankowski, 
& Lichtenberg, 2010; Jakobsson, 2007). The PCS and MCS demonstrated Cronbach 
alphas of 0.77 and 0.73 in this study. 
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Sleep was measured using both subjective and objective instruments. The 
Pittsburgh Sleep Quality Index (PSQI) measures perceived sleep quality. The tool 
contains 19 self-response items and five questions related to the bed partner that were 
not included in analysis. The PSQI responses are grouped into seven component 
scores; each weighted equally on a 0-3 scale, and summed to obtain a global score. The 
global score can range from 0 to 21 points with high scores indicating poor sleep quality. 
As recommended by developers, the global scale has a cut-off score > 5 to indicate poor 
sleepers. The PSQI subjectively measures sleep quality, sleep duration, sleep latency, 
sleep disturbances, daytime dysfunction, habitual sleep dysfunction, and sleep 
medication use (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989). This tool has 
demonstrated reliability and validity in the older adult (Spira et al., 2012) and Cronbach’s 
alpha was 0.74 in this study. 
 The Patient Reported Outcomes Measurement Information System (PROMIS)-
Sleep Disturbance SF-8A is a patient-reported sleep measure developed in partnership 
with the National Institutes of Health (Cella et al., 2010). The questionnaire contains 8 
items for sleep disturbance and sleep-related impairment. A score of 50 is considered 
average for the U.S. general population and scores can be above or below the mean 
(standard deviation = 10). T-scores above 50 indicate poor sleep. The PROMIS short 
form was shown to have greater measurement precision than the PSQI (Yu et al., 2011). 
No published report of this measurement was found in studies in community-dwelling 
older adults. The Cronbach’s alpha was 0.88 in this study. 
 Sleep-wake patterns were measured by wrist actigraphy. The wrist GT3X wrist 
actigraph by Actigraph ® (Pensacola, FL) is a non-invasive method of indirectly 
estimating sleep-wake and activity-rest patterns (Actigraph, 2016). The device is small 
and similar to a watch worn on the non-dominant wrist. It records a digitally-integrated 
measure of gross motor activity used to visualize activity-rest patterns and to quantify 
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physical activity or sleep (de Souza et al., 2003). Actigraph monitors have demonstrated 
reliability in the older adult (Rowe et al., 2008).  
 In this study, total sleep time (TST), wake after sleep onset (WASO), and wake 
percent were examined as sleep-wake parameters from the actigraph (Berger et al., 
2008). TST is the number of minutes of actual sleep while in bed and WASO minutes 
are the amount of time spent awake after the initiation of sleep (Schutte-Rodin, Broch, 
Buysse, Dorsey, & Sateia, 2008). Wake percent is the ratio of TST to the amount of time 
spent in bed divided by 100. Normal values are considered 7-9 hours for TST, less than 
30 minutes or 10% of time in bed for WASO, and a wake percent of 15% or less. Values 
not within normal limits may indicate sleep disturbance (Berger et al., 2005). Participants 
wore the actigraph for seven 24 hour cycles. Those participants with four or more nights 
of data were included in actigraphy analysis. Sleep data were analyzed using the Cole 
Kripke algorithm in the Actilife software by Actigraph ® (Pensacola, FL). The sleep diary 
in and out of bed times were used to assist with processing and analysis of the actigraph 
data.  
 Potentially Inappropriate Medications (PIMs). To identify the use of PIMs, 
prescribed and OTC medications were compared to the 2012 Beers Criteria. This study 
focused on medications and classes of medications to avoid in older adults. The criteria 
are based on a Delphi method of expert evidence base (American Geriatrics Society 
2012 Beers Criteria Update Expert Panel, 2012). All prescribed, OTC home medications 
and supplements taken within the past month were reviewed and recorded by the first 
author. Medications to be used with caution were not included for analysis. Chronic 
medication use was defined as the weekly use of a medication for the past 3 months. 
Next, the first author categorized each medication as PIMS or non-PIMS on an 
investigator-derived PIMs log. The final step was to review each medication (PIMS vs. 
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non-PIMS) with a pharmacist with expertise in geropharmacology. The medications were 
discussed until consensus was achieved at 100% agreement.  
Procedures 
 Approval of the study was obtained from the Institutional Review Board. After 
enrollment, each participant was taught how to complete the questionnaires, sleep diary, 
properly wear the wrist actigraph, and given instructions on what to bring to the clinic for 
the follow-up visit. Participants were reminded to bring all prescribed, OTC medications, 
vitamins, and herbal supplements taken in the last month from home in the red bag(s). 
      
 After 1 week, participants returned the binder of completed questionnaires, sleep 
diary, wrist actigraph, and red bag(s) of home medications, vitamins, and supplements. 
Private space in the medical clinic was used for the investigator to conduct in-person 
medication reviews and record medications in the red bag(s). Review questions 
included: how often the medication/vitamin/supplement was taken, how long taken, and 
for what diagnosis. Participants were specifically asked about the duration of use for 
pain medications and if they use substances such as caffeine or alcohol that may 
interfere with pharmacokinetics. Allergies and history of ADEs also were assessed. All 
medications, vitamins, and supplements were returned to the participant along with 
information about medication safety and a $25 gift card. Participants’ primary care 
providers were updated on each person’s home medications. 
Statistical Analysis 
 An a priori conservative sample size and power analysis was performed based 
on aim 2 using the SF-12 PCS. Since PCS is a continuous predictor and the response 
variable (PIMS use: yes vs no) is categorical, determining power and sample sizes in 
this case would be equivalent to determining power and sample sizes for a two-sample 
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two-sided t-test, comparing 2 groups (PIMS use: yes vs no) with respect to the 
continuous variable PCS.  
 The following estimates were used for the PCS means and standard deviations 
of the two groups: Group 1 (Mean = 35, SD = 8); and Group 2 (Mean = 40, SD = 10). 
The null hypothesis (Ho) in this case is that the population means for both groups were 
equal to 35, against the alternative hypothesis (Ha) that one mean is 35 whereas the 
other is 40, with the respective standard deviations. The conclusion is that group sample 
sizes of n=53 (for a total of N=106) achieve 80% power to detect a difference of 5 
between Mean=35 and Mean=40 with estimated group standard deviations of, 
respectively, 8 and 10,  and with a significance level (alpha) of 0.05 using a two-sided 
two-sample t-test.   
 Statistical analyses were performed using the SPSS version 23 software 
package. For aim 1, PIMs were categorized according to the 2012 Beers Criteria and 
coded by dummy variables (yes=1, no=0). Descriptive statistics were conducted to 
determine the proportion of participants and category of PIMs in this sample. 
Independent samples t-tests were performed to compare variables in PIMs and non-
PIMs users.  
 For aim 2, univariate descriptive statistics were performed to analyze variables of 
demographic characteristics, health experience, and health status factors. Demographic 
characteristics were coded as dummy variables (gender [male=1, female=2]; marital 
status [married or cohabitating=1, single or widowed=2]; highest education [high school 
graduate=1, college and above or trade school=2]; income [below poverty level=1, 
above poverty level=2]; home location [small rural town=7, rural=10]). The number of 
medications and health providers were counted and values were used from subjective 
questionnaires and actigraphy instruments. Chi square tests and point biserial 
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correlations were performed to explore relationships between variables. A less stringent 
p value of 0.20 was used to screen and explore potential relationships.  
 A binary logistic regression analysis was performed to determine which 
statistically significant variables predict the probability of the use of PIMs to avoid. The 
dependent variable was coded as PIMs use: yes=1 and no=0. The other numerical 
predictor variables were transformed into standardized form due to the variation of units. 
Overall model evaluation was performed. The Hosmer-Lemeshow test for logistic 
regression was performed to test the goodness of fit for the overall model. A p-value > 
0.05 on the Hosmer-Lemeshow test indicates adequate model fit (Lemeshow & Hosmer, 
1982). Due to the exploratory nature of the study, the threshold level of significance for 
individual predictors in the logistic regression was established at p<0.20. The results 
include relationships of significance and trend.  
Results 
Recruitment and Retention 
 During the recruitment period from January to October 2015, N= 141 older adults 
enrolled in the study. A total of 3 participants withdrew (2 for health reasons and 1 
reconsidered their decision after completing the questionnaires). Missing data included: 
medical record (1), < 4 nights of complete actigraphy data (6), no data related to income 
(12), and highest education level (1). 
 Sample Characteristics 
 Sample characteristics are displayed in Table 1. Participants’ mean age was 77 
years old and they took a mean of 11.6 medications and supplements and had a 
moderately high mean comorbidity score of 4.6. Participants’ mean body mass index 
was 30.5, indicative of obesity.  
 As seen in Table 2, the mean physical component score was 38.7 and mental 
component score was 53.2. These data indicate poorer self-reported physical and 
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mental health than expected for adults ages ≥65 years. The majority of participants 
(84%) reported moderate (27%) to extreme (28%) interference from pain in the past 
month that interfered with normal work. The PROMIS score of 46.9 reflected sleep 
disturbance no different than the norm but the mean PSQI score of 6.5 indicated poor 
sleep quality. Per actigraphy, TST, and wake percent were within normal limits; however 
mean WASO minutes per night (50.6) was slightly more than 10% of TST (456 minutes).  
PIMs Use 
 The prevalence of the use of PIMs to avoid was 49%; 32% of the sample used at 
least one and 17% used 2 or more PIMs. Of the participants who took PIMs, 51% used 
prescribed PIMs; 24% used OTC PIMs; and 25% used both prescribed and OTC PIMs. 
Table 3 lists the frequency of the common classifications of PIMs taken by individuals in 
this sample. NSAIDS, medications with anticholinergic properties, short acting 
benzodiazepines, and non-benzodiazepine receptor agonists were the most frequently 
used PIMs. Of the anticholinergics, antihistamines were used most often and acquired 
OTC. Of the NSAIDs, the majority also were acquired OTC.  
 Independent-samples t-tests were conducted to compare variables in PIMs and 
non-PIMs users. PIMs users were more likely to have lower physical component scores 
[M=36.8, SD=8.9; t (136) =-2.2, p = 0.024; versus M=40.6, SD=10.3] indicating poor 
physical health, more health providers [M=2, SD=0.9; t (136) =2.6, p =0.009; versus 
M=1, SD=0.8], and higher number of medications [M=13, SD=5; t (136) =4.0, p =0.001; 
versus M=10, SD=4]. There was a trend toward significance for PIMs users to have 
higher PSQI scores [M=7.1, SD=3.7; t (136) =1.8, p=0.065; versus M=6, SD=3.2] 
indicating poorer sleep quality. The use of PIMs was no different based on gender, age, 
education, or income (p> 0.05). 
 As shown in Table 4, several significant relationships were found between PIMs 
and the client singularity variables. Higher use of PIMs was associated with higher 
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number of medications, seeing more providers, poor physical health, and poor sleep 
quality (p< 0.20). The use of PIMs was not associated with comorbidity, mental health, 
self-reported sleep disturbances, or objective sleep or wake parameters (p>0.05).  
Predictors of PIMs Use 
 As seen in Table 5, a logistic regression analysis was conducted to predict the 
probability of use of PIMs. The number of medications, number of providers, physical 
component score, and PSQI were chosen as client singularity predictors. The overall 
model was examined for fit and 17% of the variance of the use of PIMs was explained by 
this model. Higher number of medications was the only significant predictor of the 
increased probability of the use of PIMs. Every increase in 1 count of medication 
increased the odds of the use of PIMs by 1.8 or 85%, 95% CI [1.19, 2.84].  
     Discussion      
 The main result was that the use of PIMs to avoid was prevalent among this 
sample of rural community-dwelling older adults. A rate of 49% of the participants took at 
least one PIM, which is higher than the national estimated prevalence of 42%. 
Consistent with national results, the participants frequently used NSAIDs and 
medications with anticholinergic properties (Davidoff et al., 2015; Kachru et al., 2015). 
The use of PIMs was associated with use of higher number of medications, higher 
number of health providers, and poor self-reported physical health. Higher number of 
medications was the single significant predictor of an increased probability of the use of 
PIMs. The following discussion will focus on results, implications for research, practice 
and conclusions. 
 Prior studies of the use of PIMs have focused on the prescribing patterns of 
health care providers. Half of the older adults in this study took prescribed PIMs. 
Prescriptions are written based on patient status and provider expertise. The benefit may 
outweigh the risk and the prescribing of PIMs may be the only viable treatment option. 
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The prevalence of prescription PIMs use may reflect the pharmaceutical management of 
chronic illness in rural areas that may be associated with obesity such as pain (National 
Conference of State Legislatures, 2013; National Rural Health Association, 2014). 
Community-dwelling older adults also contribute to the prevalence rates of the use of 
PIMs. PIMs users took both prescribed and OTC PIMs. Consistent with Arcury et al. 
(2012), independent participants seem to take OTC medicine to manage symptoms of 
disease.   
 Pain was a common symptom; it was not surprising to find participants frequently 
using PIMs with anti-inflammatory properties. Most NSAIDs were obtained OTC and this 
finding highlights the importance of provider pain assessment and prevention of long-
term NSAID use. The long-term use of NSAIDs is discouraged because it may lead to 
gastrointestinal injury, fluid retention, renal failure, and increased bleeding time in older 
adults (Gnjidic et al., 2014). Recommendations may be necessary for anti-inflammatory 
medications similar to the new recommendations that warn of acetaminophen toxicity 
(Kennelty, Parmelee, & Wilson, 2015). 
 In this study, use of PIMs was associated with poorer physical health, but not 
mental health, similar to findings reported by Fu et al. (2004). Compared to urban 
settings, individuals in rural areas are less likely to report or have access to mental and 
behavioral health specialists (Thomas, Macdowell, & Glasser, 2012). Older adults may 
not be routinely prescribed PIMs for the treatment of mental or behavioral health. In 
addition, there are few OTC medications for behavioral health and older adults may be 
seeking supplements that are not included on the Beers Criteria.  
 The use of PIMs was associated with a higher number of medications and 
visiting or seeing or seeking treatment from more health providers. Unlike previous 
studies, no association was found between PIMs use and age, gender, income, or 
comorbidity (Blalock et al., 2005; Guaraldo et al., 2011; Kachru et al., 2015). The 
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majority of participants in this study had incomes above poverty level guidelines and 
comorbidity has not been measured routinely making it difficult to compare with 
published studies. When compared to Blalock and colleagues (2005), participants in this 
study had a higher mean severity of comorbidity and this may be one reason for the 
difference in the prevalence of the use of PIMs. 
 Objective measurement by actigraphy showed sleep quantity to be within normal 
limits. Similar to previous studies, older adults self-reported poor sleep quality and use of 
PIMs to help them relax or improve their sleep (Ancoli-Israel, 2005; Ancoli-Israel, 2009; 
Lee et al., 2013; Radcliff et al., 2015; Steinman et al., 2011). Consistent with Bertisch 
and team (2014) and Basu et al. (2003), medications with benzodiazepine properties 
were prescribed to promote sleep. In this study, participant use of OTC sleep aids with 
anticholinergic properties and prescribed benzodiazepines are of concern. Medications 
with sedative and anticholinergic properties cause falls, dry mouth, dry eyes, dizziness, 
confusion, constipation, and increase the risk of delirium and dementia. Sleep problems 
may be perceived as an inevitable result of aging by older adults or health care providers 
and patients may have ambivalent feelings towards taking medications to promote sleep. 
Nevertheless, OTC medications are filling the void. With NSAIDs and medications with 
anticholinergic properties readily available for use OTC, health care professionals need 
to partner with patients to ensure safe medication management.   
  Higher number of medications was the only significant predictor for an increased 
probability of PIMs use. Consistent with Maher and colleagues (2014), polypharmacy 
increased the chance of using PIMs. This relationship highlights the necessity for all 
health care professionals to closely monitor older adults taking multiple medications.  
Strengths and Limitations  
 This study was the first to use Cox’s nursing model to describe factors 
associated with the use of PIMs to avoid. The model was beneficial for demonstrating 
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the role of client singularity in the use of PIMs. An individual’s health experience and 
their health status (self-reported physical health and sleep quality) were associated with 
the use of prescribed and OTC PIMs. The use of Cox’s model may be helpful in the 
development of nursing interventions to reduce the use of PIMs.  
 Most prior studies of PIMs have been conducted in acute or long-term care 
settings with minimal information about rural community-settings. A modest sample of 
rural older adults was obtained to explore the concepts. An additional strength is that 
medications were recorded from the participants’ actual medication and supplement 
bottles, instead of the medical record or patient lists.  PIMs were reviewed with a 
pharmacist with expertise in geropharmacology. Indirect objective measures of sleep-
wake patterns were recorded in addition to self-reported sleep. Actigraph measures 
were complete for analysis because 94% of participants wore the actigraph for the 
duration of the study.  
 In addition to strengths, the study also had limitations. Generalizability is limited 
because the convenience sample was small and mostly Caucasian. Participants were 
from a Midwest farming community, from one clinic in one rural small town and selection 
bias may have occurred. Although patients stated they brought in all medications and 
supplements for review, it is possible that participants may not have brought all 
medications taken in the last month.  
Implications for Nursing Research and Practice 
 There are several implications for research on PIMs and optimized use of 
medications in rural community-dwelling older adults. The use of PIMs needs to be 
evaluated using a standard method such as the Beers Criteria. Prospective work could 
explore PIMs in multiple outpatient settings and medical specialties. Studies need to be 
conducted in more diverse samples of older adults (Colby & Ortman, 2015); particularly, 
in rapidly growing rural populations such as the Hispanic Latino population.  
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 Interventions not only need to be initiated by physicians or pharmacists but by 
multi-disciplinary teams including nurses. In the rural primary care setting, nurses can 
collaborate with the health care team to develop interventions to reduce and monitor the 
use of prescribed and OTC PIMs. Screening tools using updated versions of the Beers 
Criteria and patient-reported ADEs can be evaluated by health care staff in primary care 
clinics. Health researchers can test randomized controlled trials that promote a team 
intervention to reduce commonly used PIMs. Studies can compare non-pharmacological 
interventions to the use or tapering of a pharmacologic intervention.  
 All health care professionals need to consistently monitor medications. Initial 
nursing assessments can encourage alternative strategies for sleep problems and pain 
in older adults. Medication reconciliation has been encouraged, but medications need to 
be critically appraised. Medication appraisal needs to identify all PIMs in older adults 
engaged in polypharmacy and in poor physical health, paying close attention to current 
use and duration of NSAIDs use and medications with central nervous system and 
anticholinergic effects. A primary care protocol could promote: 
 Regularly planned interactive medication reviews (nurse initiated with pharmacist 
available using Beers Criteria and evaluating all home prescribed and OTC 
medications, vitamins, and supplements). 
 Assessment of patient pharmaceutical literacy; provision of patient education and 
resources (PIMs and ADEs). 
 Mandatory follow-up phone calls to evaluate patients taking new medications or 
changes to regimen (blood pressure, blood sugar, hydration, CNS disturbances, 
falls, gastrointestinal disturbance). 
Conclusion 
PIMs use is a serious public health concern. This study confirmed that despite 
the evidence of risk, the use of prescribed and OTC PIMs to avoid is prevalent in rural 
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settings. The use of PIMs in rural community-dwelling older adults impacts the 
patient/family and health care team. Health care professionals in rural primary care 
settings need to collaborate with community-dwelling older adults to reduce the use of 
PIMs. 
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Figure 1. Research Model of Factors Associated with Potentially Inappropriate 
Medication Use in Community-Dwelling Older Adults adapted from Cox’s Interaction 
Model of Client Health Behavior 
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Table 1. Sample Characteristics 
Demographic Variables (N=139) 
 
Gender  
Number of 
Participants % of Participants 
Male  78 56 
Female 61 44 
Home Location  
  Small rural town  83 60 
Rural area  56 40 
 
Mean/Median SD 
BMI   30.5/29.3 6.3 
Age 77.7/78 7.3 
Young old (65-78) 51 37 
Old old (79-99) 61 44 
Race/Ethnicity 
  Caucasian 137 98 
Hispanic 1 1 
Native American/Alaskan American 1 1 
Marital Status 
 Married/Cohabitating 101 74 
Single/Widowed 36 26 
Income (N=127) 
Under Poverty (10K and below) 4 3 
Over Poverty 123 97 
Refused Answer (12)   
Highest Education (N=137) 
 12 Grade and Under 95 69 
College or Trade School 43 31 
121 
 
 
 
Table 2. Sample Characteristics of Health Experience and Health Status Variables 
Variable Mean SD 
Health Experience   
Number of Medications 11.6 4.8 
Charlson Comorbidity Index 4.6 1.5 
Number of Providers 2.0 0.8 
Health Status (N=139)*    
Physical Component Score (SF-12) 38.7 9.9 
Mental Component Score (SF-12) 53.2 8.6 
Subjective Sleep (N=139)* 
 Sleep Disturbance (PROMIS SF8a) 46.9 7.8 
Sleep Quality (PSQI Total) 6.5 3.5 
Actigraphy (N=133) 
  Total Sleep Time hours (TST) 7.2 0.9 
Wake After Sleep Onset minutes (WASO) 50.6 27.8 
Wake Percent 12.4 8.6 
Normal Values of Physical Component Score: 43.4, Mental Component Score: 55.2 for those 65 and 
older, PROMIS Sleep Disturbance: 50, PSQI Total: less than 5, TST: 7-9 hours, WASO: less than 30 
minutes or 10% of time in bed, Wake Percent: 15% or less 
Note. * participants completed questionnaires only 
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Note. *several 
participants use more than one classification of PIMs to avoid 
 
Table 3. Characteristics of PIMs To Avoid (N=138) 
             N 
Number 
of Participants 
Using Medicines 
% of Participants 
Using Medicine 
One PIM 138 44 32 
Two or More PIMs 138 23 17 
Total PIMs use  67 49 
Prescribed PIMs 67 34 51 
Over the Counter PIMs 67 16 24 
Taking Prescribed and Over the Counter PIMs 67 17 25 
    
Classification of Most Common PIMS to Avoid*  
  Anticholinergics 67 19 28 
            Antihistamines (84% of anticholinergics) 67 16 24 
                       Prescribed (11% of antihistamines) 67 2 3 
                       OTC (94% of antihistamines) 67 15 22 
            Skeletal Muscle Relaxants 67 2 3 
           Tricyclic Antidepressants 67 3 4 
Alpha 1 Blockers 67 12 18 
Short Acting Benzodiazepines 67 12 18 
Non benzodiazepine Receptor Agonist 67 4 6 
Estrogen 67 7 10 
Non-Steroidal Anti-inflammatory Drugs (NSAID) 67 22 33 
                        Prescribed (32% of NSAIDs) 67 7 11 
                        OTC (68% of NSAIDs) 67 15 22 
History of Falls with Benzodiazepines 67 6 9 
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Table 4. Correlations between Demographic, Health Experience and Health Status Variables and use of PIMs (N=138) 
 
Variable PIMs to Avoid (r) 
Age  0.004 
Charlson Comorbidity  0.081 
Number of Medications  0.331** 
Number of Providers  0.223** 
Physical Component Score (S) -0.193* 
Mental Component Score (S) -0.031 
Pittsburgh Sleep Quality Index (S)  0.158† 
PROMIS Sleep Disturbance (S)  0.073 
Total Sleep Time (A) -0.102 
Wake After Sleep Onset (A) -0.027 
Wake % (A) -0.059 
Note. A= Actigraph, S= Self-report, *p<0.05 (2-tailed), **p<0.01 (2-tailed), †trend for correlation p<0.20 
 
Table 5. Summary of Binary Logistic Regression Analysis Predicting Probability of use of PIMs  
Predictor Variables Unstandardized 
B 
Standard Error Wald’s X2 Exponential 
β 
Odds Ratio 
P value  
Number of Medications     0.619              0.224      7.62 1.858*             0.006     
Number of Providers   0.220                 0.206     1.15 1.247  0.284   
Physical Component Score   -0.154                 0.202     0.58 0.857  0.446   
Pittsburgh Sleep Quality Index   0.180                 0.187            0.92 1.19  0.336 
Note. Hosmer Lemeshow Test (H-L) model of good fit p>.05  
Nagelkerke R2 = .179, X2(8)= 14.18 H-L p=.07, *p<.05 (2-tailed)  
124 
 
CHAPTER V: CONCLUSIONS AND DISCUSSION 
  
125 
 
CHAPTER V: CONCLUSIONS AND DISCUSSION 
Summary 
 This dissertation study was developed from the progression of knowledge 
focusing on PIMs use in older adults. Components of this process included formalized 
coursework and application of this knowledge to scientific inquiry. The following 
paragraphs are a summary of the knowledge development previously presented in 
Chapters I-IV followed by a discussion on the dissertation results and findings.  
 Chapter I was an introduction of the scholarly activities presented in the 
dissertation. The goal of pharmacological management is to ease symptoms or alleviate 
disease. Treatment success may depend on patient adherence to the right medication, 
dosage, at the right time, and frequency. However a problem may arise when the older 
adult adheres to medications that may be inappropriate. Health professionals and older 
adults need to understand factors and outcomes associated with PIMs to avoid. 
 Chapter II presents an integrative literature review on PIMs use. As with any 
scholarly endeavor, I reviewed previously published literature about PIMs use in older 
adults. This process allowed me to examine how PIMs have been defined, measured, 
prospectively and retrospectively analyzed, and led to additional questions to address 
knowledge gaps. There are plenty of studies on the use of PIMs in long-term care and 
acute settings, but not in community-dwelling older adults. More studies need to 
examine the use of PIMs and PIMs to avoid in ambulatory or community-dwelling 
settings.  The concept of PIMs use has not been extensively studied in independent 
older adults. This presents a problem in methodology of how PIMs are measured. In 
community-dwelling samples this is especially important because older adults not only 
take prescribed medications, but also OTC medications. In community-dwelling samples, 
researchers have examined PIMs operationally in terms of prescribed medications, 
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overlooking the reality that older adults are independent and may take other medications 
than what has been prescribed.  
 Existing studies have provided insight to the awareness and estimated 
prevalence of the problem of PIMs use. Studies exploring PIMs use have used large 
databases with lists of prescribed medications. Medication lists may not contain OTC 
medications, especially if the provider is unaware of their use. Independence of 
community-dwelling older adults is eliminated when studies only examine PIMs that are 
prescribed. Are there other factors that are associated with PIMs use that have not been 
explored? Factors that are associated with PIMs use may be different based on 
individuality or client singularity factors. In community-dwelling older adults, PIMs use 
may be underestimated and thus needs to be explored in terms of concept.  In addition, 
interventions have lacked a collaborative model including the patient and nurse as active 
partners in medication management with health care providers and pharmacists. 
Interventions targeting the provider or pharmacist may only be effective for prescribed 
medications, once again leaving out medications that can be purchased OTC in 
pharmacies, grocers, bulk supply, or online.  
 Chapter III described sleep and health-related factors in a sample of midlife and 
older rural women. Through this secondary analysis, I was able to observe the 
characteristics of specific factors of client singularity (i.e. demographics, sleep, and 
health status). Chronic conditions and their symptoms such as pain may be caused by 
poor sleep or cause poor sleep and the following questions arise. Is poor sleep properly 
managed or treated in this population?  Do these individuals self-manage poor sleep? In 
order to globally capture sleep characteristics and their association with other variables, 
both subjective and objective instruments are needed. Sleep characteristics are 
associated with several health-related factors, thus sleep behavior is an important 
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element in health. The use of nurse-led non-pharmacological interventions may 
successfully influence patient behavior and lead to improved sleep and physical and 
mental health.   
 Building on the knowledge from the integrative review and secondary analysis, I 
was able to identify possible client singularity factors of independence from Cox’s 
Interaction Model of Client Health Behavior were associated with and predictors of PIMs 
use in rural community-dwelling older adults.  Chapter IV presents the third manuscript 
for this dissertation study that descriptively analyzed use of PIMs to avoid in rural older 
adults. Specific aims of the manuscript were:  
1) Describe the use of PIMs to avoid in rural community-dwelling older adults ≥ 65 years. 
2) Explore individual demographic characteristics (age, gender, income, education, and 
home location), health experience (comorbidity, number of medications and health 
providers), and health status factors (physical and mental function, sleep disturbance, 
sleep quality, and 24 hour sleep-wake patterns) as predictors of use of PIMs to avoid.  
 An additional manuscript is based on the results of the third aim of the 
dissertation study. Results can be found in the Appendix A. The third specific aim was: 
3) Examine individual demographic characteristics, health experience, health status, and 
use of PIMs to avoid as predictors of patient-reported ADEs.  
The following paragraphs summarize major findings discussed in Chapter IV.              
Conclusions and Discussion 
 Published evidence suggests the need to limit the use of potentially inappropriate 
medications (PIMs) in older adults. Aim 1 was to describe the use of PIMs in rural 
community-dwelling older adults ≥ 65 years. 
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 The use of PIMs to avoid was prevalent among this sample of rural community-
dwelling older adults. Participants took PIMs at a higher prevalence rate than the 
national estimated prevalence. Consistent with national results, there was frequent use 
of NSAIDs and medications with anticholinergic properties (Davidoff et al., 2015; Kachru, 
Carnahan, Johnson, & Aparasu, 2015). The use of PIMs to avoid was associated with 
several client singularity factors but higher number of medications was the only 
significant predictor of an increased probability of PIMs use. The following discussion will 
focus on the results, conclusions gained from this study, and implications for future 
research and practice. 
 The use of prescribed PIMs is important but should not be the primary focus of 
study in independent older adults. Half of the older adults in this study took at least one 
prescribed PIM. Providers are prescribing medications that may have more risk than 
benefit in rural community-dwelling older adults. Older adults in this study had moderate 
severity of comorbidity, were obese, and had lower than normal self-reported physical 
and mental health. The high prevalence of prescription PIMs use may reflect the 
pharmaceutical management of chronic disease in rural areas (National Conference of 
State Legislatures, 2013; National Rural Health Association, 2014). Community-dwelling 
older adults in this sample also contribute to the prevalence rates PIMs use. Participants 
took prescribed and OTC, or primarily OTC PIMs. Consistent with findings by Arcury et 
al. (2012), participants take OTC medicine to manage symptoms. 
 Pain was a common symptom; therefore it was not surprising to find the high 
frequency of participants using PIMs with anti-inflammatory properties. Most of the 
NSAIDs were obtained OTC and draws attention to the importance of provider pain 
assessment and prevention of long-term NSAID use. As observed in the study by Gnjidic 
et al. (2014), long-term use of NSAIDs is discouraged because of the risk of adverse 
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events. Recommendations may be necessary for anti-inflammatory medications that are 
similar to warnings associated with acetaminophen toxicity (Kennelty, Parmelee, & 
Wilson, 2015).  
 As previously reported, PIMs use was associated with lower physical health (Fu, 
Liu, & Christensen, 2004). Although older adults tend to score normal on the mental 
component and poorer on physical component, both were lower than norms for adults 
ages 65 and older (Ware, Kosinski, & Keller, 1996).  No association was found between 
PIMs use and mental health. This result could be explained by the lack of OTC 
medications for mood and limited mental and behavioral health specialists in rural areas 
(Thomas, Macdowell, & Glasser, 2012). The use of PIMs was associated with a higher 
number of medications and health providers but not with age demographic, gender, or 
comorbidity (Blalock et al., 2005; Guaraldo, Cano, Damasceno, & Rozenfeld, 2011; 
Kachru et al., 2015). These results could be explained by the small sample size and 
incomes above poverty levels. Income was analyzed based on falling above or below 
federal poverty level guidelines; this may limit our ability for comparison with published 
literature. Also, comorbidity has not been consistently measured for comparison to 
previous studies. 
 Although sleep disturbance was no different than the norm, participants had high 
minutes awake after falling asleep and poor self-reported sleep quality. Higher minutes 
awake after falling asleep in this sample may be related to nocturia. Sleep-wake 
parameters using actigraphy were within normal limits but older adults reported poor 
sleep quality; consistent with findings from (McCrae et al., 2005). 
 The use of prescription and OTC sleep medications by this sample is consistent 
with the sample in the national report (Basu, Dodge, Stoehr, & Ganguli, 2003; Bertisch, 
Herzig, Winkelman, & Buettner, 2014). Participants in this rural sample used sleep 
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medications with benzodiazepine and anticholinergic properties that are of concern due 
to their risk for causing ADEs (Ancoli-Israel, 2005; Ancoli-Israel, 2009; Lee et al., 2013; 
Radcliff et al., 2015; Steinman, Handler, Gurwitz, Schiff, & Covinsky, 2011). As NSAIDs 
and medications with anticholinergic properties continue to be available OTC, the use in 
older adults needs to be monitored.   
  Aim 2 was to explore individual demographic characteristics (age, gender, 
income, education, and rural home location), health experience (comorbidity, number of 
medications and health providers), and health status factors (physical and mental 
function, sleep disturbance, sleep quality, and 24 hour sleep-wake patterns) as 
predictors of PIMs use. 
 A regression model was fit to determine predictors of increased probability of the 
use of PIMs. Higher number of medications was the significant predictor for increased 
probability of the use of PIMs to avoid. This relationship highlights the necessity to 
monitor older adults with polypharmacy. Consistent with Maher, Hanlon, & Hajjar (2014) 
polypharmacy increases the chances of using PIMs, therefore older adults’ medications 
need to be routinely evaluated. Health care professionals need to continuously appraise 
medications older adults are taking, particularly if they are taking three or more 
prescribed and OTC medications and supplements. In rural community-dwelling older 
adults, PIMs use is not only based on the behavior of the prescribing provider; the 
patient plays also plays a role. As shown by the model, client singularity is an important 
factor in the use of PIMs. Multi-disciplinary models may guide screening of medications 
with the patient, in order to promote appropriate medication use behaviors and 
monitoring of medication management.  
 Aim 3 was to examine individual demographic characteristics, health experience, 
health status, and PIMs use as predictors of patient-reported ADEs. 
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 An association was found between PIMs to avoid and patient-reported ADEs. 
Unlike previous reports, logistic regression results showed the use of PIMs to avoid was 
not a significant predictor of the increased odds of patient-reported ADEs (Chrischilles, 
VanGilder, Wright, Kelly, & Wallace, 2009; Lund, Carnahan, Egge, Chrischilles, & 
Kaboli, 2010). Although this study is unable to declare causality, a trend towards 
significance is logical. Patient-reported ADEs were CNS disturbances and dry mouth, 
events that could occur from the use of PIMs with benzodiazepine and anticholinergic 
properties. 
 The use of PIMs to avoid as a non-significant predictor was an unexpected 
finding because the Beers criteria were derived as a resource to prevent incidents such 
as ADEs. Similar findings have been reported in studies in patients admitted to acute 
settings (Budnitz, 2011; Hamilton, Gallagher, Ryan, Byrne, & O'Mahony, 2011; Laroche, 
Charmes, Nouaille, Picard, & Merle, 2007). Studies on PIMs and ADEs are difficult to 
compare due to a variety of conceptual and operational definitions and measurement.  
 Older age (79 to 99 years) did not increase the probability of patient-reported 
ADEs. Older adults may view an ADE as a part of a comorbid condition flare, or just wait 
to see if things improve. Younger age (65 to 78), lower physical health, and poor sleep 
quality were significant predictors of the increased odds of patient-reported ADEs. Older 
adults with lower physical health and poor sleep quality may be susceptible to alterations 
in pharmacokinetic and pharmacodynamics leading to ADEs (Bressler & Bahl, 2003). 
Older adults may not report a symptom, it is up to the health care team to frequently 
evaluate and assess pharmaceutical management. The use of PIMs to avoid showed a 
trend towards significance to increase the probability of patient-reported ADEs and 
health care professionals need to consider other aspects of health status when 
monitoring and evaluating ADEs in older adults.  
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     Limitations      
 There were several strengths of this study. This study was the first to use Cox’s 
nursing model (1982) to observe factors and outcomes associated with the use of PIMs 
to avoid. This study sampled rural older adults; a population that has been neglected in 
prior studies. Rural settings are commonly difficult to recruit and obtain a desired study 
sample, and this modest sample helped the exploration of the concepts. Community-
dwelling older adults were observed, where most studies have assessed those who are 
hospitalized and or living in long-term care settings. This study is of importance as our 
baby-boomers are remaining independent in their homes or in community apartment-
style settings. Medications were recorded using the participants’ actual medication and 
supplement bottles instead of the medical record or patient lists. In addition to self-
reported sleep characteristics, indirect objective measures of activity-rest and sleep-
wake were measured. An expert pharmacist in geropharmacology reviewed the 
medications and patient-reported ADEs.  
 Despite the strengths, our study is not without limitations. First, a convenience 
sample that was small in size was used that limited generalizability of the findings. 
Sampling was performed from only one family practice clinic in one Midwestern rural 
small town, instead of multiple settings and towns. Selection bias may have occurred as 
well. Although patients stated that they brought in all medications and supplements for 
review, there is a chance they did not bring all medications. Furthermore, our study used 
self-report measures.  The Naranjo Algorithm was not used to attribute the use of PIMs 
to avoid to ADEs, and all patient-reported ADEs could not be verified via medical record 
(Naranjo et al., 1981).  
Implications 
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 There are implications for additional research related to PIMs and optimized 
medication use in rural community-dwelling older adults. Additional prospective studies 
could explore the use of PIMs in large samples in outpatient settings and specialties 
where patients are 65 and older. Studies should not only characterize subjects by age 
group, but by “medical specialty” to explore if specific specialty clinics have a higher 
prevalence of the use of PIMs to avoid. Sample sizes need to be large. As our aging 
population becomes more diverse, studies need to include different ethnicities. It is 
estimated that the U.S. Hispanic Latino population will become the new majority minority 
and this population, in addition to the American Indian population, have comorbidities 
and gaps in care in rural areas. 
  Interventions not only need to be initiated by physicians or pharmacists but by 
nurses as well. Nurses can collaborate on a research team to develop interventions to 
monitor and reduce the use of PIMs to avoid and ADEs. Screening tools for health care 
staff using updated versions of PIMs, and patient-reported ADEs can be tested in 
primary care clinics. Interventions can be developed targeting those at risk for using 
PIMs (i.e. older adults with polypharmacy and poor health status). Randomized 
controlled trials can be led by nurse scientists that study non-pharmacological 
interventions that may influence sleep and pain and reduce PIMs use. Studies can 
compare non-pharmacological interventions to the use or tapering of a pharmacologic 
intervention.  
 The monitoring of medication needs to go beyond medication reconciliation, and 
promote appraisal. For instance, nurses can assess and notify the health care team on 
the current use and duration of NSAID use and medications with CNS and 
anticholinergic effects. Patients need to be monitored for anticholinergic burden from the 
use of multiple medications. Initial nursing assessments of sleep problems or pain in 
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older adults may encourage the use pain and sleep diaries to document characteristics 
of these symptoms. Nurses can promote the use of alternative strategies for problems 
with pain and sleep. Examples include topical pain preparations and sleep hygiene. 
 When a provider determines that a PIM is necessary, the nurse needs to contract 
close follow-up and evaluation of ADEs. Patients need to be educated about PIMs. If 
patients decide to use PIMs, they also need to be educated about ADEs to report. For 
example, educate about short term use and potential consequences of use 
(cardiovascular, cerebrovascular, renal, GI disturbances, dry mouth, dry eyes and 
impaired gait and risk for dementia) of NSAIDs or medications with CNS or 
anticholinergic effects. Health care providers need to communicate medication 
adjustments with specialty providers. Interprofessional teams in rural primary care clinics 
can develop protocols to manage polypharmacy and imbed updated Beers criteria into 
screenings. A culture of adhering to current pain and sleep-wake guidelines needs to be 
enforced in pharmaceutical management in the older adult (Barkin et al., 2010).  
 In order for these activities to take place, implications for education and policy 
need to be considered. In terms of education, nursing pharmacology courses need to be 
more in depth. The Beers criteria need to be included in course content where geriatric 
considerations are taught. Interprofessional concepts need to be linked into the 
curriculum to promote a team based approach to geriatric care. This includes 
pharmacological concepts, where resources such as the Beers criteria are applied in a 
consistent manner. Nurses may value how other health professions come to decisions 
about pharmaceutical management, and vice versa; with all developing a healthy 
respect to the knowledge and skill each profession brings to the team. The Beers criteria 
are used by the Centers for Medicare and Medicaid Services and insurance companies 
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to promote appropriate prescribing; however, in terms of policy follow-up has to be done 
to see if this has made an impact. 
 This study confirmed that despite the evidence of risk, PIMs use remains 
prevalent and may be underestimated. In particular, prescribed and OTC PIMs to avoid 
are being taken by rural community-dwelling older adults. Of notable concern are 
NSAIDs and medications with anti-cholinergic and sedative properties because of the 
increased risk of ADEs. Although causality could not be confirmed in our study several 
ADEs are similar to the effects reported to be caused by frequently used PIMs to avoid.  
 Chapters I through IV present the gradual building of nursing scholarly inquiry 
related to PIMs. The use of PIMs to avoid is associated with the number of providers, 
and self-reported poor physical health in independent older adults but the increased 
probability of the use of PIMs to avoid is predicted by a high number of medications. 
Patient-reported ADEs also are associated with client singularity variables but the 
increased probability is predicted by younger age (65 to 78), self-reported lower physical 
health, poorer sleep, and the use of PIMs to avoid. The use of PIMs to avoid in rural 
community-dwelling older adults is an issue that impacts the patient/family, pharmacist, 
nurse, and prescribing health care providers. The reduction of the use of PIMs to avoid 
and prevention of ADEs may require interventions that target both prescribing health 
care providers and independent older adult patients. 
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Appendix A. Patient-Reported ADEs in Rural Older Adults 
Abstract 
 Adverse drug events (ADEs) are a major contributing factor in the health and 
safety of older adults.  Older adults may experience ADEs that they ignore or self-
manage. This behavior can lead to a clinic, emergency or hospital visit, impacting health 
status and costs. The purpose of this study was to explore the characteristics and 
predictors of patient-reported ADEs in rural community dwelling older adults. Participants 
(N=138) underwent one-on-one reviews of all prescribed and over-the-counter 
medications, vitamins, and supplements. The 2012 Beers Criteria were used to record 
PIMs to avoid. Data were collected on participant’s demographics, subjective physical 
and mental health and sleep, objective sleep-wake patterns, and patient-reported ADEs. 
One or more ADEs was reported by 48% of participants. The most frequently reported 
ADEs by participants were central nervous symptom disturbances (16%), dry mouth 
(12%), hoarseness, gastrointestinal irritation, and decreased libido (8%). Higher patient-
reported ADEs were associated with poor sleep and poor physical health (p<0.05). 
Younger age (65 to 78), poor physical health, and poor sleep quality were significant 
predictors of an increased probability of patient-reported ADEs (p<0.05). These results 
suggest that health care professionals in rural areas need to use strategies to reduce 
ADEs in rural community-dwelling older adults. Interventions should engage patients and 
their families by specifically targeting older adults with poor health status, taking multiple 
medications, and using PIMs to avoid. 
 
 
Keywords: Medications, Adverse Drug Events, Rural, Older adults 
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Introduction 
The prevention of adverse drug events (ADEs) has become a national priority. 
An ADE is any injury resulting from a pharmaceutical intervention (Institutes of Medicine, 
2007; Kohn, Corrigan, & Donaldson, 2000). Reports claim that ADEs result in high 
morbidity and medical expenditure and the estimates of outpatient ADEs vary with a 
higher incidence occurring in adults ages 65 and older (Bourgeois, Shannon, Valim, & 
Mandl, 2010). The estimated prevalence of ADEs related to prescribed medications in 
older adults has ranged from 18% to 30% (Chrischilles, VanGilder, Wright, Kelly, & 
Wallace, 2009; Tache, Sonnichsen, & Ashcroft, 2011). Literature is limited about ADEs 
among older adults in rural community settings because ADEs have primarily been 
studied in acute care settings (Pretorius, Gataric, Swedlund, & Miller, 2013). 
 Studies have examined the associations between ADEs and the use of specific 
medication classes. Community-dwelling older adults have reported adverse events, 
such as falls, when taking potentially inappropriate medications (PIMs) (Koyama, 
Steinman, Ensrud, Hillier, & Yaffe, 2014; Landi et al., 2007; Lukazewski, Mikula, Servi, & 
Martin, 2012; Martin, Tamblyn, Ahmed, & Tannenbaum, 2013). The chronic use of PIMs, 
such as non-steroidal anti-inflammatory drugs (NSAIDs), has been associated with 
negative gastrointestinal, renal, cardiovascular, cerebrovascular, and central nervous 
system events in older adults (Marcum & Hanlon, 2010).  
 Several studies have refuted the association between ADEs and PIMs use, and 
concluded that other medications are more of a risk. Other medication categories (i.e. 
cardiovascular, hypoglycemic, and anticoagulants) have been associated with over 27% 
of preventable ADEs in a sample of U.S. community-dwelling older adults (Davies & 
O'Mahony, 2015; Ducoffe et al., 2015; Gurwitz et al., 2003). Compared with other 
medications, the use of PIMs resulted in fewer emergency department visits for ADEs 
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(Budnitz, 2011). Other studies reported similar results among older patients admitted 
into acute care (Hamilton, Gallagher, Ryan, Byrne, & O'Mahony, 2011; Laroche, 
Charmes, Nouaille, Picard, & Merle, 2007). 
 ADEs in ambulatory older adults have been reported to be predicted by the use 
of a higher number of medications, warfarin, and benzodiazepine drugs (Gandhi et al., 
2003; Hanlon, Schmader, & Semla, 2013; Pretorius et al., 2013). Several criteria such as 
the Beers Criteria have been created to help reduce the occurrence of ADEs by 
targeting PIMs. However, the predictive relationship between ADEs and the use of PIMs 
is complex. Older adults with multiple comorbidities were found to be at increased risk 
for ADEs in the ambulatory setting when taking non-opioid analgesics and diuretics 
(Field et al., 2004). Every increase in one count of inappropriately prescribed medication 
predicted an increase in the odds of an ADE (OR 1.13) (Lund, Carnahan, Egge, 
Chrischilles, & Kaboli, 2010). Another study found that those who used inappropriate 
medications had 2.14 increased odds of developing a self-reported ADE (Chrischilles et 
al., 2009). Unfortunately, studies have used differing methodologies to measure ADEs 
which may contribute to the varied results.  
 Rural community-dwelling older adults are using both prescribed and OTC 
medications to self-manage health conditions and symptoms (Shade, Berger, Chaperon, 
Haynatzki, Sobeski, Yates, 2016). A patient symptom could be an ADE that is 
undetected by health care providers because it is managed by the use of OTC 
medications and/or other self-care behaviors. Health care providers need to recognize 
and monitor for risks associated with all prescribed and OTC medications and 
supplements used by community-dwelling older adults.  
  PIMs use may be necessary in specific chronic conditions. More studies need to 
examine the relationship between patient-reported ADEs, PIMs use, and client-
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singularity factors such as demographics and self-reported health-status, in rural 
community-dwelling older adults. Therefore, the dissertation study also examined 
patient-reported ADEs in rural community-dwelling older adults ≥ 65 years old. In 
addition to describing patient-reported ADEs, the third specific aim was to: Examine 
individual demographic characteristics, health experience, health status, and the use of 
PIMs to avoid as predictors of patient-reported ADEs. 
Methods 
 The detailed methods and procedures are detailed in Chapter IV. The following 
paragraphs will briefly re-iterate the methods and procedures.  
Study Design  
 This study used an exploratory descriptive study design guided by a derivative of 
Cox’s Interaction Model of Client Health Behavior (IMCHB) (Cox, 1982). Client 
singularity factors of demographic characteristics, health experience, health status, and 
PIMs use were examined as predictors of the health outcome of patient-reported ADEs. 
Study Sample/Setting 
 A convenience sample of older adults from a rural family practice clinic in the 
Midwest was recruited. The rural urban commuting area (RUCA) codes were used to 
classify rural status. Male and female patients were screened for participation according 
to inclusion and exclusion criteria.  
 Inclusion criteria were: men and women ≥ 65 years of age, living independently 
in the community, took ≥ 3 prescribed medications, scored ≥ 26 on the Montreal 
Cognitive Assessment (MOCA)(Nasreddine et al., 2005), and available during the data 
collection period. Exclusion criteria were: older adults not responsible for self-
medication, inpatient in acute hospital or living in long-term care facilities, unable to 
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complete questionnaires, do not read and speak English, and currently taking 
medications for cognitive impairment. 
Measurements 
 Demographic Characteristics. Data were collected on participant’s age, 
gender, education, zip code, marital status, and household income. 
 Health Experience. Participants were asked about the number of medications 
taken and their current number of health providers. Data on medications taken in the last 
month included: prescribed, over the counter, herbal, vitamin, and supplements. Names 
of drugs, dosage, frequency, and length of use were verified with patient records. 
Additional information such as the routine for taking medications and pharmacies used 
were recorded. Medical diagnoses were recorded from each participant’s medical 
records. The Charlson Comorbidity Index was used to assess comorbidity (Charlson, 
Szatrowski, Peterson, & Gold, 1994; Charlson, Pompei, Ales, & MacKenzie, 1987).  
 Health Status. The 12-Item Medical Outcomes Survey (MOS) Short Form (SF-
12) was developed to describe patient-reported physical and mental health status and to 
measure health related QOL (Ware, Kosinski, & Keller, 1996). The tool has established 
reliability and validity in the older adult (Cernin, Cresci, Jankowski, & Lichtenberg, 2010; 
Jakobsson, 2007). The Cronbach’s alpha for this study was 0.82. 
 Sleep. Sleep was observed using both subjective and objective instruments. The 
Pittsburgh Sleep Quality Index (PSQI) and Patient Reported Outcomes Measurement 
Information System (PROMIS)-Sleep Disturbance SF-8A measured self-reported sleep 
quality and disturbance (Buysse, Reynolds, Monk, Berman, & Kupfer, 1989; Cella et al., 
2010). The Cronbach’s alphas for this study were 0.74 and 0.88, respectively. Sleep-
wake patterns were measured by wrist actigraphy. The GT3X wrist actigraph by 
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Actigraph ® (Pensacola, FL) is a non-invasive method of indirectly estimating sleep-
wake and activity-rest patterns (Actigraph, 2016). Total sleep time (TST), wake after 
sleep onset (WASO), and wake percent were obtained (Berger et al., 2008).  
 Potentially Inappropriate Medications (PIMs). All prescribed, OTC home 
medications and supplements taken within the month were brought to the clinic for 
review. Participant medications were compared to the 2012 Beers criteria. The criteria 
are based on a Delphi method of expert evidence base (American Geriatrics Society 
2012 Beers Criteria Update Expert Panel, 2012). Chronic medication use was defined as 
the weekly use of a medication for the past 3 months. The PIMs used were recorded on 
an investigator-derived PIMs use log. 
 Patient-Reported Adverse Drug Events (ADEs). For this study, ADEs were 
defined as any injury resulting from a pharmacological medical intervention (Institute of 
Medicine, 2007; Kohn et al., 2000). ADEs were explained to the participant as any 
unintended, undesirable, or harmful effect resulting from the treatment of a medication 
(Bates et al., 1995; Gandhi et al., 2003). Participants were given an adapted version of 
an adverse event questionnaire with drug-related symptoms (Corso, Pucino, DeLeo, 
Calis, & Gallelli, 1992). The questionnaire contained 23 dichotomous (yes/no) questions 
that assess participant ADE’s from the previous month. A pharmacist with expertise in 
geropharmacology to review recorded PIMs and patient-reported ADEs. 
Procedures 
 Approval of the study was obtained from the Institutional Review Board. After 
enrollment, each participant was taught how to complete the questionnaires, sleep diary, 
properly wear the wrist actigraph, and was given instructions on what to bring to the 
clinic for follow-up. Participants were instructed to bring prescribed, OTC medications, 
vitamins, and herbal supplements taken in the last month from home in the red bag(s). 
155 
 
Participants were given a reminder call two days prior to the follow-up visit (Shade et al., 
2016).       
 After 1 week, participants returned the binder of completed questionnaires, sleep 
diary, wrist actigraph, and red bag(s) of home medications, vitamins, and supplements. 
Private office space in the medical clinic was used to conduct an in-person medication 
review. The investigator recorded medications in the red bag(s). All medications, 
vitamins, and supplements were returned to the participant along with information about 
medication safety and a $25 gift card. Participants’ primary care providers at the medical 
clinic were given a medication update form in a binder that listed 1) all reviewed 
medications taken in the last month, 2) medications on the medical record, and 3) the 
2012 Beers Criteria medications (Shade et al., 2016). 
Statistical Analysis 
 For aim 3 univariate descriptive statistics were performed to analyze predictor 
variables of demographic characteristics, health experience, and health status factors. 
Chrischilles et al. (2009), found a one-year self-reported ADE prevalence of 30% in older 
adults who were prescribed at least one PIM. Patient-reported ADEs was estimated to 
be higher for this study because a larger percentage of participants used PIMs to avoid. 
 Demographic characteristics were coded as dummy variables (male=1, 
female=2; married or cohabitating=1, single or widowed=2; high school graduate=1, 
college and above or trade school=2; below poverty level=1, above poverty level=2; 
small rural town=7, rural=10). Age was divided into 2 groups (65 to 78, and 79 to 99) by 
a median split. The number of medications and health providers were counted, and 
values (rather than dummy variables) were used from subjective questionnaires and 
actigraphy instruments. Chi square tests and point biserial correlations were performed 
to explore relationships between variables. We used a less stringent p value of 0.20 to 
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screen and explore potential relationships. A binary logistic regression analysis was 
performed to determine which statistically significant variables predict the probability of 
the use of PIMs to avoid. The dependent variable was coded as ADEs: (yes=1 and 
no=0). Due to the variation of units, the other numerical predictor variables were 
transformed into standardized form so that all units were standard deviations. An 
evaluation was performed on the overall model fit. The Hosmer-Lemeshow test for 
logistic regression was performed to test the goodness of fit for the overall model. A 
Hosmer-Lemeshow test with a p-value greater than 0.05 indicates adequate model fit 
(Lemeshow & Hosmer, 1982). 
Results 
Characteristics of Patient-Reported ADEs 
 Table 1 lists the frequency of participants who reported ADEs. One or more ADE 
was reported by 48% of participants. As seen in Table 1 the most frequently reported 
ADEs were CNS disturbances (16%), dry mouth (12%), and hoarseness, gastrointestinal 
irritation, and decreased libido (all 8%). Of those who used at least one PIM, 59% of 
participants had at least one patient-reported ADE. Demographic variables of patients 
who reported ADEs were different based on age (X2= 4.1; p=0.04) and PIMs use (X2= 
7.3; p=0.007). Participant-reported ADEs were no different based on gender, rural home 
location, highest education achieved, or income (p>0.05).  
 As shown in Table 2, there was a trend for association between patient-reported 
ADEs and higher number of medications and lower mental component score. Higher 
number of patient-reported ADEs was weakly associated with poorer sleep quality [PSQI 
(r=0.233, p=0.006)] and with sleep disturbance [PROMIS (r=0.231, p=0.006)] and poor 
physical health status (r=0.336, p=0.0001). Patient-reported ADEs were not associated 
with comorbidity or sleep-wake parameters from actigraphy (p>0.05).  
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 Table 3 presents a logistic regression analysis conducted to predict the 
probability of patient reported ADEs. The number of medications, age by median split, 
PCS, MCS, PSQI, and use of PIMs to avoid were predictors. The overall model was 
examined for fit and 26% of the variance of the use of PIMs to avoid was explained by 
this model.  The odds of patient reported ADEs are 0.4 less or 60% decreased in those 
aged (79-99); than those who are 65-78 95% CI [0.20, 0.96].  
 The odds of patient reported ADEs are 0.4 less or 60% decreased with a 
standard deviation decrease of physical component score; than those with higher 
physical component scores or poorer physical health, 95% CI [0.32, 0.74]. Higher PSQI 
score was the significant predictor of the increased probability of patient reported ADEs. 
Every standard deviation increase in PSQI score increased the odds of patient reported 
ADEs by 1.5 or 57%, 95% CI [1.0, 2.4]. The use of PIMs to avoid was not a significant 
predictor of patient-reported ADEs (OR 2.06, p= 0.06), but showed a strong trend. The 
odds of patient reported ADEs are 2.0 more in those who use PIMs to avoid; than those 
who do not use PIMs to avoid. 
     Discussion      
 The older adults in this sample reported ADEs such as CNS disturbances, dry 
mouth, and GI irritation. Patient-reported ADEs were associated with age, physical 
health, sleep quality, sleep disturbances, and the use of PIMs to avoid. Younger age (65 
to 78), poor physical health, and poor sleep quality were significant predictors of the 
increased probability of patient-reported ADEs. The following discussion highlights the 
study’s results and provides implications for research and practice.  
 This study found 48% of older adults reported ADEs. Previous prevalence 
estimates are lower and may be attributed to studies examining ADEs associated only 
with prescribed medications (Chrischilles et al., 2009; Tache et al., 2011). Previous 
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studies examined the association of ADEs with specific medications. Complimentary to 
Marcum et al. (2010) Chapter IV results confirmed participants’ use of anticholinergic 
medications and other PIMs to avoid such as short acting benzodiazepine and NSAIDs. 
This study was unable to determine the causality of ADEs, yet several risks associated 
with the use of these medications are frequent patient-reported ADEs.  
 There was a difference in patient-reported ADEs based on age. Patient-reported 
ADEs were associated with lower physical health, poor sleep quality, sleep disturbances, 
and the use of PIMs to avoid. Older age (79-99) was did not increase the probability of 
reported ADEs. Older adults may view an ADE as a part of a comorbid condition flare, 
may wait to see if things improve, or exhibit stoicism and not report an event.  
 This study did not predict patient-reported ADEs based on specific medication 
class as previous studies (Gandhi et al., 2003; Hanlon et al., 2013; Pretorius et al., 
2013). Lower physical health and poor sleep quality were significant predictors of the 
increased odds of patient-reported ADEs. Results reinforce older adults’ susceptibility to 
the alterations in pharmacokinetic and pharmacodynamics factors that are associated 
with ADEs (Bressler & Bahl, 2003; Field et al., 2004). 
 Unlike previous reports the use of PIMs to avoid only had a predictive trend to 
increase the odds of patient-reported ADEs (p=0.06) (Chrischilles et al., 2009; Lund et 
al., 2010). Similar findings have been reported in patients admitted to acute settings 
(Budnitz, 2011; Hamilton et al., 2011; Laroche et al., 2007). Although we are unable to 
declare causality, the trend towards significance is logical because several patient-
reported ADEs were CNS disturbances and dry mouth, all events that could occur from 
the use of PIMs with benzodiazepine and anticholinergic properties. Although the Beers 
Criteria were derived as a resource to prevent incidents such as ADEs, other factors 
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such as physical health, sleep quality, and age may be important variables to consider 
while preventing ADEs.  
Strengths and Limitations 
 This study was the first to use Cox’s nursing model to describe factors 
associated with patient-reported ADEs. Most prior studies have been conducted in acute 
settings and this study was performed in a rural community-setting. Commonly rural 
settings are difficult to recruit and a modest sample was obtained. Instead of using lists, 
data were recorded from participants’ medications and supplement bottles. This study 
measured both self-reported and indirect objective activity-rest and sleep-wake patterns. 
A pharmacist with expertise in geropharmacology reviewed PIMs and patient-reported 
ADEs.  
 The study also had limitations. A small mostly Caucasian convenience sample in 
a farming community in the Midwest limits the generalizability of the findings. The 
recruitment of participants from one clinic in a small rural town may have resulted in 
selection bias. Patients may have forgotten to bring in all medications and supplements 
for review. The study did not use the Naranjo Algorithm to determine if the ADEs were 
due to medication rather than other health-related factors (Naranjo et al., 1981). 
Implications 
 There are several implications for nursing research. Comparing results from 
studies about ADEs is difficult due to the variety of conceptual and operational definition 
and measurement of PIMs and ADEs. We recommend using the use of the definition 
developed by the Institute of Medicine (2007). When appropriate, studies need to use 
the Naranjo Algorithm to determine the probability of a medication causing an ADE. 
Future studies need to be performed in multiple community settings. Large longitudinal 
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studies can explore patient-reported ADEs further examining older adult and family 
member knowledge about ADEs and self-efficacy with medication management. To 
reduce ADEs, team-based interventions need to be developed that target older adults 
with poor physical health and poor sleep quality.  
 There also are implications for nursing practice. Nursing professionals in rural 
settings can help develop a family/caregiver resources or tools to help recognize ADEs. 
Nurses can help educate older adults about the importance of communicating with the 
provider regarding falls or sudden symptoms. Those who are older may not report a 
problem and nurses as part of the health care team need to frequently evaluate and 
assess problems with pharmaceutical therapies. The Beers Criteria may be beneficial 
but health care professionals also need to consider other aspects of health status when 
monitoring older adults for ADEs. 
Conclusion 
 Patient-reported ADEs are prevalent in rural community-dwelling older adults. 
Events such as CNS disturbances and GI irritation may lead to additional negative 
health outcomes in older adults, including falls, hospitalization or increased health costs. 
The results of this study suggest that health care professionals need to develop 
strategies to prevent ADEs in rural community-dwelling older adults by targeting older 
adults with poor health status, taking multiple medications, and using PIMs to avoid. 
Engagement of the patient and family as full partners with the health care team is vital. 
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Table 1. Characteristics of  Patient-Reported ADEs (N=138)    
                                                                             Number  
                                                                            of Participants         % of Participants  
Ecchymosis 9 6  
Arthralgia and Myalgia 7 5  
Xerophthamia and Vision disturbance 3 2  
Rhinorrhea or Epistaxis 3 2  
Xerostoma 16 12 
 Dysgeusia 5 4 
 Hoarse 11 8  
Gastrointestinal Irritation 11 8 
 Bowel (constipation or diarrhea) 10 7 
 Urination (increased frequency) 7 5 
 
Decreased libido or sex organ dysfunction 11 8 
 
CNS disturbance (dizziness, sleepy) 22 16  
Total 115* 83*  
Note. 66 participants (48%) had patient-reported ADEs and 59% of those taking 1 or more PIMs to avoid had at least one patient-reported ADE 
*Some participants had more than one classification of patient-reported ADE 
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Table 2 Correlations between Patient-Reported ADEs and Demographic, Health Experience, Health Status Variables, and use of 
PIMs to Avoid (N=138) 
Variable Patient-Reported ADEs (r) 
Age -0.087 
Charlson Comorbidity -0.100 
Number of Providers  0.108 
Number of Medications  0.151 
Physical Component Score (S) -0.336** 
Mental Component Score (S) -0.113
† 
Pittsburgh Sleep Quality Index (S)  0.233** 
PROMIS Sleep Disturbance (S)  0.231** 
Total Sleep Time (A)  0.020 
Wake After Sleep Onset (A) -0.057 
Wake % (A) -0.032 
Note. A= Actigraph, S= Self-report; *p<.05 (2-tailed), **p<.01 (2-tailed), 
†
trend for correlation p<0.20 
Table 3 Summary of Binary Logistic Regression Analysis Predicting Probability of Patient-Reported ADEs 
Predictor Variables Unstandardized 
B 
Standard 
Error 
Wald’s X
2 
Exponential β 
Odds Ratio 
 P value 
Number of Medications            -.149            0.218  0.467      0.861  0.494 
Age (79 to 99)  -0.807                   0.395                 4.16     0.446*  0.041 
Physical Component Score   -0.716                   0.212               11.42     0.489*  0.001 
Mental Component Score  -0.121                   0.209                 0.332     0.886  0.565 
Pittsburgh Sleep Quality 
Index 
  0.451                   0.219                 4.26     1.57*  0.039 
PIMs to Avoid   0.727                   0.400                 3.30      2.06
†
  0.069 
Note. Hosmer Lemeshow (H-L) test for good model fit p>0.05. 
Nagelkerke R
2 
= .265, X
2
(8) = 12.0 H-L p=.150, *p<.05 (2-tailed), 
†
trend 
Younger age (65 to 78) was a significant predictor of higher probability of patient-reported ADEs. 
 
